Monensin

Cattle (heifers fed in confinement for slaughter)

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes, and for suppression of estrus (heat) in heifers fed in confinement for slaughter for the last 28 to 42 days on feed.

Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at time of loading. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Ractopamine HCl is not for animals intended for breeding.Special considerations:Mixing directions for liquid melengestrol acetate Type C feeds stored in recirculation tank systems, labeling indicates: “Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents from the bottom of the tank to the top. Recirculate daily, as directed in this paragraph even when the Type C feed is not used.” For liquid melengestrol Type C feeds stored in mechanical, air or other agitation-type tank systems: “Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily, as directed in this paragraph, even when the Type C feed is not used.”

Optaflexx™ and Rumensin™ and Tylan™and MGA®

Cattle (heifers fed in confinement for slaughter)

Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter.

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian. Feed continuously as sole ration to heifers at a rate of 0.5 to 2.0 pounds per head per day to provide 0.25 to 0.5 mg/head/day melengestrol acetate and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day and 60 to 90 mg/head/day tylosin. The melengestrol acetate portion of this Type C medicated feed must be mixed into the complete feed containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin at feeding into the amount of complete feed consumed by an animal per day. Melengestrol acetate is for use only in heifers being fed in confinement for slaughter. Not effective in steers or spayed heifers. Heifers fed in confinement for slaughter: Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at the time of loading. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.

HeifermaX™ 500 / Rumensin™ / Tylan™

Cattle (heifers fed in confinement for slaughter)

For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), for the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii; and for reduced incidence of liver abscesses caused by Fusobacterium necrophorum and Actinomyces (Corynebacterium) pyogenes.

For heifers fed in confinement for slaughter.

MGA® 100 / Rumensin® / Tylan®

Cattle (heifers fed in confinement for slaughter)

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and suppression of estrus (heat) in heifers fed in confinement for slaughter for the last 20 to 40 days on feed.

Feed as the sole ration for the final 20 to 40 days. Do not use in calves to be processed for veal. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Zilpaterol hydrochloride is not for use in animals intended for breeding. Do not allow horses or other equines access to feed containing zilpaterol. Do not use in veal calves. Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90% dry matter basis), zilpaterol should not be fed in complete feed. Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days or more should be avoided to prevent the possibility that the heifers may come into estrus (heat) at loading time.

Heifermax® 500/Zilmax®/Rumensin®

Cattle (Fed in Confinement for Slaughter)

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii in cattle fed in confinement for slaughter during the last 20 to 40 days on feed.

Feed continuously during the last 20 to 40 days on feed. Special considerations: 1) Labeling of Type C cattle feeds shall bear the following: (i) Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. (ii) Zilpaterol hydrochloride is not for use in animals intended for breeding. (iii) Do not allow horses or other equines access to feed containing zilpaterol. (iv) Do not use in veal calves. 2) Labeling of Type C complete feeds must bear the following caution statement: CAUTION: Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90% dry matter basis), zilpaterol should not be fed in complete feed.

Zilmax®/Rumensin®/MGA®

Cattle (Heifers Fed in Confinement for Slaughter)

For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat).

Feed continuously during the last 20 to 40 days on feed. Special considerations: 1) Labeling of Type C cattle feeds shall bear the following: (i) Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. (ii) Zilpaterol hydrochloride is not for use in animals intended for breeding. (iii) Do not allow horses or other equines access to feed containing zilpaterol. (iv) Do not use in veal calves. 2) Labeling of Type C complete feeds must bear the following caution statement: CAUTION: Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90% dry matter basis), zilpaterol should not be fed in complete feed. 3) Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days or more should be avoided to prevent the possibility that the heifers may come into estrus (heat) at loading time.

Zilmax®/Rumensin®/MGA®

Cattle (beef heifers fed in confinement for slaughter)

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and suppression of estrus (heat) in heifers fed in confinement for slaughter for the last 28 to 42 days on feed.

Feed continuously as sole ration during the last 28 to 42 days on feed. Not for animals intended for breeding. Do not use in calves to be processed for veal.

Heifermax 500®/Optaflexx®/Rumensin®

Cattle (fed in confinement for slaughter)

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 20 to 40 days on feed.

Feed continuously during the last 20 to 40 days on feed. Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.Zilpaterol hydrochloride is not for use in animals intended for breeding. Do not allow horses or other equines access to feed containing zilpaterol. Do not use in veal calves. Animals receiving zilpaterol hydrochloride may exhibit increased respiratory rate aswell as elevated levels of creatine phosphokinase (CPK) and creatine.Special considerations:1) Labeling for Type B feeds used to manufacture Type C complete feeds must bear the caution statement: Not to be fed to cattle in excess of 90 mg/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90 percent dry matter basis), zilpaterol should not be fed in complete feed. 2) Type B Liquid Feeds can be manufactured containing 68 to 680 g zilpaterol hydrochloride/ton. Inadequate mixing (recirculation or agitation) of monensin liquid Type B or Type C medicated feeds has resulted in increased monensin concentration, which has been fatal to cattle. For liquid feeds stored in recirculating tank systems: Recirculate immediately prior to use for not less than 10 minutes, moving not less than 1 percent of the tank contents per minute from the bottom of the tank to the top. Recirculate daily as described even when not used. For liquid feeds stored in mechanical, air or other agitation-type tank systems: Agitate immediately prior to use for not less than 10 minutes, creating turbulence at the bottom of the tank that is visible at the top. Agitate daily as described even when not used.3) All labeling for Type B and Type C feeds provides the warning: The active ingredient in Zilmax® is zilpaterol hydrochloride, a beta2-adrenergic agonist. Not for use in humans. An anti-dust process has been applied to the drug product, Zilmax®, in order to greatly reduce inhalation risk. Extended handling tasks with the potential for dust generation require respiratory protection. Wear appropriate skin protection (e.g., impervious gloves, apron, overalls), if there is a potential for extended skin contact. Wear protective eyewear, if there is a potential for eye contact. If accidental eye contact occurs, immediately rinse with water and consult a physician.

Zilmax® and Rumensin™ and Tylan™

Cattle (growing beef heifers fed in confinement for slaughter)

For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and the prevention and control of coccidiosis caused Eimeria bovis and Eimeria zuernii.

HeifermaX™ and Rumensin™

Cattle fed in confinement for slaughter

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed.

Feed continuously as sole ration to provide 90 to 430 mg ractopamine per hd/day and 0.14 to 0.42 mg monensin per lb body weight/day (depending on severity of coccidiosis challenge, up to 480 mg/hd/day), and 60 to 90 mg tylosin per hd/day for the last 28 to 42 days on feed. Labeling: The labeling of dry Type B feeds containing ractopamine, monensin, and tylosin intended for use in cattle shall bear the following caution statements: Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Ractopamine HCl is not for animals intended for breeding. The labeling of liquid Type B feeds containing ractopamine, monensin and tylosin intended for use in cattle shall bear the following caution statements: Inadequate mixing (recirculation or agitation) of monensin liquid Type B medicated feed has resulted in increased monensin concentration, which has been fatal to cattle. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle. Must be thoroughly mixed in feeds before use. Do not feed undiluted. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any liquid feed containing sodium metabisulfite or in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Expiration Date: 31 days after the date of manufacture. Ractopamine HCl is not for animals intended for breeding. The labeling of all Type C feeds containing ractopamine, monensin, and tylosin intended for use in cattle shall bear the following caution statements: Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Ractopamine HCl is not for animals intended for breeding.

Optaflexx™ and Rumensin™ and Tylan™

Cattle fed in confinement for slaughter

For prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii and control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of cattle fed in confinement for slaughter, where active BRD has been diagnosed in at least 10% of the animals in the group.

Pulmotil™ and Monovet®

Cattle fed in confinement for slaughter

For improved feed efficiency and control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of cattle fed in confinement for slaughter, where active BRD has been diagnosed in at least 10% of the animals in the group.

Pulmotil™ and Monovet®

Cattle fed in confinement for slaughter

For improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle being fed in confinement for slaughter.

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Rumensin® plus Tylovet® 100

Cattle fed in confinement for slaughter

For increased rate of weight gain, improved feed efficiency, increased carcass leanness and prevention and control of coccidiosis due to Eimeria bovis and E. zuernii in cattle fed in confinement for slaughter during the last 28 to 42 days on feed.

Actogain™ and Monovet®

Cattle fed in confinement for slaughter

For prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes.

Rumensin™ and Tylan™

Cattle fed in confinement for slaughter

For improved feed efficiency and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter.

Monovet® and Tylovet®

Cattle fed in confinement for slaughter

For improved feed efficiency and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes.

Feed only to cattle being fed in confinement for slaughter. Feed continuously as sole ration to provide 50 to 480 monensin mg/hd/day and 60 to 90 tylosin mg/hd/day. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 g/ton (360 mg monensin per head per day).

Rumensin™ and Tylan™

Cattle fed in confinement for slaughter

For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter during the last 28 to 42 days on feed.

Optaflexx™and Monovet® and Tylovet®

Cattle fed in confinement for slaughter

For reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes.

Optigrid® and Monovet® and Tylovet®

Cattle fed in confinement for slaughter

For improved feed efficiency and for prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii.

Optigrid® and Monovet®

Cattle fed in confinement for slaughter

For increased rate of weight gain, improved feed efficiency, and increased carcass leanness.

Optigrid® and Monovet® and Tylovet®

Cattle fed in confinement for slaughter

For prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii.

Actogain™ and Monovet®

Cattle fed in confinement for slaughter

For increased rate of weight gain and improved feed efficiency.

Optigrid® and Monovet® and Tylovet®

Cattle Fed in Confinement for Slaughter

For prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii and control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pastuerella multocida, and Histophilus somni in groups of cattle fed in confinement for slaughter, where active BRD has been diagnosed in at least 10% of the animals in the group.

The safety of tilmicosin has not been established in cattle intended for breeding purposes. Tilmicosin is not approved for use in female dairy cattle 20 months of age or older. Use in these cattle may cause drug residues in milk. Tilmicosin is not approved for use in calves intended to be processed for veal. For cattle fed in confinement for slaughter, feed continuously for 14 days to provide 12.5 mg tilmicosin/kg/head/day. Feed at a rate of 0.14 to 0.42 milligram monensin per pound of body weight per day, depending upon the severity of challenge, up to maximum of 480 milligrams per head per day.

Pulmotil® 90 and Rumensin® 90

Cattle Fed in Confinement for Slaughter

For improved feed efficiency and control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pastuerella multocida, and Histophilus somni in groups of cattle fed in confinement for slaughter, where active BRD has been diagnosed in at least 10% of the animals in the group.

The safety of tilmicosin has not been established in cattle intended for breeding purposes. Tilmicosin is not approved for use in female dairy cattle 20 months of age or older. Use in these cattle may cause drug residues in milk. Tilmicosin is not approved for use in calves intended to be processed for veal. Feed only to cattle being fed in confinement for slaughter. Feed continuously for 14 days to provide 12.5 mg tilmicosin/kg/head/day. Tilmicosin is not approved for use in calves intended to be processed for veal. Feed continuously in complete feed at a rate of 50 to 480 milligrams of monensin per head per day. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 grams per ton (360 milligrams per head per day).

Pulmotil® 90 and Rumensin® 90

Cattle Fed in Confinement for Slaughter

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and prevention and control of coccidiosis due to Eimeria bovis and E. zuernii in cattle fed in confinement for slaughter during the last 28 to 42 days on feed.

Feed continuously as sole ration for the last 28 to 42 days on ration. Not for animals intended for breeding. Do not use in calves to be processed for veal.

Optaflexx™ plus Rumensin®

Growing beef steers and heifers fed in confinement for slaughter

For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii , for improved feed efficiency, and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in growing beef steers and heifers fed in confinement for slaughter.

Deccox® and Rumensin™ and Tylovet®

Growing beef steers and heifers fed in confinement for slaughter

For reduction of ammonia gas emissions per pound of live weight and hot carcass weight and prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

Experior™ and Rumensin™

Growing beef steers and heifers fed in confinement for slaughter

For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline and for the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii.

Pennchlor® and Monovet®

Growing beef steers and heifers fed in confinement for slaughter

For the control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline and for the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii.

Pennchlor® and Monovet®

Growing beef steers and heifers fed in confinement for slaughter

For reduction of ammonia gas emissions per pound of live weight and hot carcass weight and improved feed efficiency in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

Experior™ and Rumensin™

Growing beef steers and heifers fed in confinement for slaughter

For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline and for improved feed efficiency.

Pennchlor® and Monovet®

Growing beef steers and heifers fed in confinement for slaughter

For the control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline and for improved feed efficiency.

Pennchlor® and Monovet®

Growing beef steers and heifers fed in confinement for slaughter

For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii, and improved feed efficiency in cattle being fed in confinement for slaughter

Feed as sole ration to provide 22.7 milligrams of decoquinate per 100 lbs of body weight per day and 50 to 360 milligrams of monensin per head per day. Feed for at least 28 days during periods of coccidiosis exposure or when experience indicates that coccidiosis is likely to be a hazard. Do not feed to cows producing milk for human consumption. A withdrawal period has not been established for this product in pre-ruminant calves. Do not use in calves to be processed for veal. Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feeds are safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusal and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Deccox® and Rumensin™

Growing beef steers and heifers fed in confinement for slaughter

For the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii.

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Rumensin™ 90

Growing beef steers and heifers fed in confinement for slaughter

For improved feed efficiency.

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Rumensin™ 90

Heifers Fed in Confinement for Slaughter

For prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, for increased carcass leanness, improved feed efficiency, increased rate of weight gain and for suppression of estrus (heat).

Feed continuously as sole ration during the last 28 to 42 days on feed. Not for animals intended for breeding.

Optaflexx™ / Rumensin® / MGA®

Beef Cows

For the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii.

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Rumensin™ 90

Beef Cows

For improved feed efficiency when receiving supplemental feed.

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Rumensin™ 90

Growing beef steers and heifers on pasture (stocker, feeder, and slaughter) or in a dry lot and Replacement beef and dairy heifers

For the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii.

Free-Choice (Self-Fed) Medicated Feeds: All Free-choice medicated feeds must provide not less than 50 nor more than 200 mg monensin per head per day.

Monovet® 90

Growing beef steers and heifers on pasture (stocker, feeder, and slaughter) or in a dry lot and Replacement beef and dairy heifers

For coccidiosis prevention and control

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Type C free-choice medicated feeds All Type C free-choice medicated feeds containing Rumensin must be manufactured according to an FDA-approved formula/specification. When using a formula/specification published in the Code of Federal Regulations (CFR), a Medicated Feed Mill license is not required. Use of Rumensin in a proprietary formula/specification not published in the CFR requires prior FDA approval and a Medicated Feed Mill license.

Rumensin™ 90

Growing beef steers and heifers on pasture (stocker, feeder, and slaughter) or in a dry lot and Replacement beef and dairy heifers

For increased rate of weight gain.

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Rumensin™ 90

Calves (excluding veal calves)

For the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii.

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Rumensin™ 90

Dairy Cows

For increased milk production efficiency (production of marketable solids-corrected milk per unit of feed intake).

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. You may notice reduced voluntary feed intake in dairy cows fed monensin. This reduction increases with higher doses of monensin fed. Rule out monensin as the cause of reduced feed intake before attributing to other causes such as illness, feed management, or the environment. You may notice reduced milk fat percentage in dairy cows fed monensin. This reduction increases with higher doses of monensin fed. You may notice increased incidence and treatment of cystic ovaries and metritis, reduced conception rates, increased services per animal, and extended days open and corresponding calving intervals in dairy cows fed monensin. Have a comprehensive and ongoing nutritional, reproductive and herd health program in place when feeding monensin to dairy cows.

Rumensin™ 90

Cattle (heifers fed in confinement for slaughter

Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter.

Feed continuously as sole ration to heifers at a rate of 0.5 to 2.0 pounds per head per day to provide 0.25 to 0.5 mg/head/day melengestrol acetate and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day and 60 to 90 mg/head/day tylosin. The melengestrol acetate portion of this Type C medicatedfeed must be mixed into the complete feed containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin at feeding into the amount of complete feed consumed by an animal per day.Melengestrol acetate is for use only in heifers being fed in confinement for slaughter. Not effective in steers or spayed heifers. Heifers fed in confinement for slaughter: Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at the time of loading.Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.

MGA® and Rumensin™ and Tylan™

Growing beef steers and heifers on pasture (stocker, feeder, and slaughter)

For increased rate of weight gain.

PASTURE GAINER BLOCK 20 R350 is a free-choice protein block containing 175 mg monensin per pound. Feed one block for every four (4) cattle. Place near watering or loafing areas in a well-drained area. Cattle should consume from 4.0 to 18.0 ounces (0.25 to 1.13 lb) per head per day to provide 40 to 200 mg monensin per head per day. Consumption of this block may vary with temperature and/or quality of forage. If consumption of the block is below 4.0 ounces per head per day, increase number of feeding locations or relocate the blocks to a more frequented area. Blocks should be replenished every 7 to 14 days. Do not allow cattle access to salt or minerals while being fed this block. Ingestion by cattle of monensin at levels of 600 mg per head per day and higher has been fatal. Do not allow horses or other equines access to feed containing monensin. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions; reduced average daily gains may result. Do not feed to sheep due to high levels of supplemental copper.

Pasture Gainer Block 20 R350

Cattle (pasture cattle: slaughter, stocker, feeder, and dairy and beef replacement heifers)

Increased rate of weight gain.

Block to be fed free choice. Provide at least 1 block per 5 head of cattle. Feed blocks continuously. Do not feed salt or minerals containing salt. Do not allow horses or other equines access to formulations containing monensin (ingestion of monensin by equines has been fatal). The effectiveness of this block in cull cows and bulls has not been established.

Sweetlix Rumensin® Pressed Block

Cattle (growing beef steers and heifers on pasture (stocker, feeder, and slaughter) and replacement beef heifers on pasture)

For increased rate of weight gain, and for prevention and control of coccidiosis caused by Eimeria bovis and E. zuernii in growing beef steers and heifers on pasture (stocker, feeder, and slaughter) and replacement beef heifers on pasture which may require supplemental feed.

MoorMan's® Mintrate® Blonde Block RU

Growing beef heifers fed in confinement for slaughter

For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), for reduction of ammonia gas emissions per pound of live weight and hot carcass weight, and for the prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii, and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in growing beef heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

MGA® and Experior™ and Monovet® and Tylovet®

Growing beef heifers fed in confinement for slaughter

For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), for reduction of ammonia gas emissions per pound of live weight and hot carcass weight, and for the prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii in growing beef heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

MGA® and Experior™ and Rumensin™

Growing beef heifers fed in confinement for slaughter

For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and the prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii.

MGA® and Rumensin™

Cattle (Heifer)

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes and suppression of estrus (heat) in heifers fed in confinement for slaughter for the last 20 to 40 days on feed.

Feed continuously as the sole ration for the final 20 to 40 days. Do not use in calves to be processed for veal. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feeds is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Zilpaterol hydrochloride is not for use in animals intended for breeding. Do not allow horses or other equines access to feed containing zilpaterol. Do not use in veal calves. Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90% dry matter basis), zilpaterol should not be fed in complete feed. Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days or more should be avoided to prevent the possibility that the heifers may come into estrus (heat) at loading time. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian. Special considerations: 1) For liquid melengestrol acetate Type C feeds stored in recirculation tank systems, labeling indicates: “Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents from the bottom of the tank to the top. Recirculate daily, as directed in this paragraph even when the Type C feed is not used.” For liquid melengestrol Type C feeds stored in mechanical, air or other agitation-type tank systems: “Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily, as directed in this paragraph, even when the Type C feed is not used.” 2) All labeling for Type C feeds containing zilpaterol hydrochloride provides the warning: The active ingredient in Zilmax® is zilpaterol hydrochloride, a beta2-adrenergic agonist. Not for use in humans. An anti-dust process has been applied to the drug product, Zilmax®, in order to greatly reduce inhalation risk. Extended handling tasks with the potential for dust generation require respiratory protection. Wear appropriate skin protection (e.g., impervious gloves, apron, overalls), if there is a potential for extended skin contact. Wear protective eyewear, if there is a potential for eye contact. If accidental eye contact occurs, immediately rinse with water and consult a physician.

Heifermax® 500/Zilmax®/Rumensin®/Tylan®

Cattle, Beef, Heifers fed in confinement for slaughter

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes, and for suppression of estrus (heat) in heifers fed in confinement for slaughter for the last 28 to 42 days on feed.

Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at time of loading. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian. Ractopamine HCl is not for animals intended for breeding. Special considerations: Mixing directions for liquid melengestrol acetate Type C feeds stored in recirculation tank systems, labeling indicates: “Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents from the bottom of the tank to the top. Recirculate daily, as directed in this paragraph even when the Type C feed is not used.” For liquid melengestrol Type C feeds stored in mechanical, air or other agitation-type tank systems: “Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily, as directed in this paragraph, even when the Type C feed is not used.”

Optaflexx™ 45/Rumensin®/Tylovet® 100/MGA®

Cattle, Beef, Heifers fed in confinement for slaughter

For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Feed only to cattle being fed in confinement for slaughter. Feed continuously as sole ration. A withdrawal time has not been established in pre-ruminating calves. Do not use in calves to be processed for veal.

MGA®, Rumensin™ and Tylovet® 100

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed.

Feed continuously as sole ration to provide 90 to 430 mg/hd/day ractopamine and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day and 60 to 90 mg/hd/day tylosin for the last 28 to 42 days on feed.

Actogain® and Rumensin™ and Tylan™

Heifers fed in confinement for slaughter

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes, and for suppression of estrus (heat) in heifers fed in confinement for slaughter for the last 28 to 42 days on feed.

Optigrid® and Monovet® and Tylovet® and CycleGuard®

Heifers fed in confinement for slaughter

For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter.

CycleGuard® and Monovet® and Tylovet®

Heifers fed in confinement for slaughter

For increased rate of weight gain, improved feed efficiency, increased carcass leanness and prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and increased rate of weight gain and for suppression of estrus (heat) in cattle fed in confinement for slaughter during the last 28 to 42 days on feed.

Optigrid® and Monovet® and CycleGuard®

Heifers fed in confinement for slaughter

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and suppression of estrus (heat) in heifers fed in confinement for slaughter for the last 28 to 42 days on feed.

Feed continuously as sole ration during the last 28 to 42 days on feed. Not for animals intended for breeding. Do not use in calves to be processed for veal.

Actogain® and Rumensin™ and MGA®

Heifers fed in confinement for slaughter

For increased rate of weight gain, improved feed efficiency, increased carcass leanness and prevention and control of coccidiosis due to Eimeria bovis and E. zuernii in cattle fed in confinement for slaughter during the last 28 to 42 days on feed.

Actogain™ and Monovet® and MGA®

Heifers fed in confinement for slaughter

For reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes.

Optigrid® and Monovet® and Tylovet® and MGA®

Heifers fed in confinement for slaughter

For improved feed efficiency and for the prevention and control of coccidiosis due to Eimeria bovis and E.zuernii.

Optigrid® and Monovet® and Tylovet® and MGA®

Heifers fed in confinement for slaughter

For increased rate of weight gain, improved feed efficiency and suppression of estrus (heat).

Optaflexx™ and Monovet® and Tylovet® and MGA®

Heifers fed in confinement for slaughter

For increased rate of weight gain, improved feed efficiency, and increased carcass leanness.

Optigrid® and Monovet® and MGA®

Cattle, Beef heifers fed in confinement for slaughter

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes and suppression of estrus (heat) in heifers fed in confinement for slaughter for the last 28 to 42 days on feed.

Feed continuously as sole ration during the last 28 to 42 days on feed. Not for animals intended for breeding. Do not use in calves to be processed for veal.Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Actogain™ 45/Rumensin®/Tylan®/MGA®

Cattle, Beef fed in confinement for slaughter

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed.

Feed a minimum of 1.0 lb/hd/day continuously to cattle fed in confinement for slaughter, to provide 70 to 400 mg/head/day ractopamine for the last 28 to 42 days on feed. Feed on top of a ration containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin phosphate, to provide 0.14 to 0.42 mg monensin/lb body weight/day (depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day), and 60 to 90 mg/hd/day tylosin. Ractopamine HCl is not for animals intended for breeding. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Optaflexx™ 45/Rumensin®/Tylovet® 100

Growing beef steers and heifers on pasture (stocker, feeder, and slaughter) and replacement beef heifers on pasture

For increased rate of weight gain.

Blocks to be fed free choice. Provide at least one block per five head of cattle. Feed blocks continuously. Discontinue feeding if block consumption falls below 2 oz. or rises above 8 oz daily. Do not feed salt or mineral supplements in addition to the blocks. Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result

CATTLE BLOCK RU-MIN

Cattle (beef fed in confinement for slaughter)

For prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii and control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pastuerella multocida, and Histophilus somni in groups of cattle fed in confinement for slaughter, where active BRD has been diagnosed in at least 10% of the animals in the group.

The safety of tilmicosin has not been established in cattle intended for breeding purposes. Cattle intended for human consumption must not be slaughtered within 28 days of the last treatment with tilmicosin. Tilmicosin is not approved for use in female dairy cattle 20 months of age or older. Use in these cattle may cause drug residues in milk. Tilmicosin and monensin are not approved for use in calves intended to be processed for veal. A withdrawal period has not been established in pre-ruminating calves.

Tilmovet® 90 and Rumensin® 90

Cattle (beef fed in confinement for slaughter)

For improved feed efficiency and control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pastuerella multocida, and Histophilus somni in groups of cattle fed in confinement for slaughter, where active BRD has been diagnosed in at least 10% of the animals in the group.

The safety of tilmicosin has not been established in cattle intended for breeding purposes. Cattle intended for human consumption must not be slaughtered within 28 days of the last treatment with tilmicosin. Tilmicosin is not approved for use in female dairy cattle 20 months of age or older. Use in these cattle may cause drug residues in milk. Tilmicosin and monensin are not approved for use in calves intended to be processed for veal. A withdrawal period has not been established in pre-ruminating calves.

Tilmovet® 90 and Rumensin® 90

Beef cows

For the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii.

Monovet® 90

Beef cows

For improved feed efficiency when receiving supplemental feed.

Monovet® 90

Beef steers and heifers fed in confinement for slaughter

For reduction of ammonia gas emissions per pound of live weight and hot carcass weight, prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii, and reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

Experior™ and Rumensin™ and Tylan™

Beef steers and heifers fed in confinement for slaughter

For reduction of ammonia gas emissions per pound of live weight and hot carcass weight, improved feed efficiency, and reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

Experior™ and Rumensin™ and Tylan™

Beef steers and heifers fed in confinement for slaughter

For reduction of ammonia gas emissions per pound of live weight and hot carcass weight and prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

Experior™ and Monovet®

Beef steers and heifers fed in confinement for slaughter

For reduction of ammonia gas emissions per pound of live weight and hot carcass weight and improved feed efficiency in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

Experior™ and Monovet®

Growing beef heifers and heifers fed in confinement for slaughter

For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii and improved feed efficiency in growing beef steers and heifers fed in confinement for slaughter.

Deccox® and Monovet®

Beef calves 2 months of age and older, and growing beef steers and heifers fed in confinement for slaughter

For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline and for the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii in growing beef steers and heifers fed in confinement for slaughter.

Pennchlor® and Rumensin™

Beef calves 2 months of age and older, and growing beef steers and heifers fed in confinement for slaughter

For the control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline and for the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii in growing beef steers and heifers fed in confinement for slaughter.

Pennchlor® and Rumensin™

Beef calves 2 months of age and older, and growing beef steers and heifers fed in confinement for slaughter

For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline and for the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii in beef calves 2 months of age and older.

Pennchlor® and Rumensin™

Beef calves 2 months of age and older, and growing beef steers and heifers fed in confinement for slaughter

For control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline and for the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii in growing beef steers and heifers fed in confinement for slaughter under 700 lbs.

Pennchlor® and Rumensin™

Beef calves 2 months of age and older, and growing beef steers and heifers fed in confinement for slaughter

For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline and for improved feed efficiency in growing beef steers and heifers fed in confinement for slaughter.

Pennchlor® and Rumensin™

Beef calves 2 months of age and older, and growing beef steers and heifers fed in confinement for slaughter

For the reduction of the incidence of liver abscesses and for the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii in growing beef steers and heifers fed in confinement for slaughter over 400 lbs.

Pennchlor® and Rumensin™

Beef calves 2 months of age and older, and growing beef steers and heifers fed in confinement for slaughter

For control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline and for improved feed efficiency in growing beef steers and heifers fed in confinement for slaughter under 700 lbs.

Pennchlor® and Rumensin™

Beef calves 2 months of age and older, and growing beef steers and heifers fed in confinement for slaughter

For the reduction of the incidence of liver abscesses and for improved feed efficiency in growing beef steers and heifers fed in confinement for slaughter over 400 lbs.

Pennchlor® and Rumensin™

Replacement beef and dairy heifers

For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline and for the prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii in replacement beef and dairy heifers.

Pennchlor® and Rumensin™

Replacement beef and dairy heifers

For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline and for increased rate of weight gain in replacement beef and dairy heifers.

Pennchlor® and Rumensin™

Beef calves 2 months of age and older

For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline and for the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii.

Pennchlor® and Monovet®

Growing beef steers and heifers fed in confinement for slaughter over 700 lbs

For control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline and for the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii.

Pennchlor® and Monovet®

Growing beef steers and heifers fed in confinement for slaughter over 700 lbs

For control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline and for improved feed efficiency.

Pennchlor® and Monovet®

Growing beef steers and heifers fed in confinement for slaughter over 400 lbs

For the reduction of the incidence of liver abscesses and for the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii.

Pennchlor® and Monovet®

Growing beef steers and heifers fed in confinement for slaughter over 400 lbs

For the reduction of the incidence of liver abscesses and for improved feed efficiency.

Pennchlor® and Monovet®

Growing beef steers and heifers fed in confinement for slaughter under 700 lbs

For control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline and for the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii.

Pennchlor® and Monovet®

Growing beef steers and heifers fed in confinement for slaughter under 700 lbs

For control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline and for improved feed efficiency.

Pennchlor® and Monovet®

Cattle/growing beef steers and heifers fed in confinement for slaughter

For increased rate of weight gain and improved feed efficiency, the prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii, and reduction of incidence of liver abscesses in growing beef steers and heifers fed in confinement for slaughter during the last 28 to 42 days on feed when ractopamine hydrochloride is used as a top dress with rations containing monensin and virginiamycin.

Optaflexx™ and Rumensin™ and V-Max®

Cattle/growing beef steers and heifers fed in confinement for slaughter

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, the prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii, and reduction of incidence of liver abscesses in growing beef steers and heifers fed in confinement for slaughter during the last 28 to 42 days on feed.

Optaflexx™ and Rumensin™ and V-Max®

Cattle/growing beef steers and heifers fed in confinement for slaughter

For reduction of ammonia gas emissions per pound of live weight and hot carcass weight, the prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii, and reduction of incidence of liver abscesses in growing beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

Experior™ and Rumensin™ and V-Max®

Cattle/growing beef steers and heifers fed in confinement for slaughter

For reduction of ammonia gas emissions per pound of live weight and hot carcass weight, improved feed efficiency, and reduction of incidence of liver abscesses in growing beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

Experior™ and Rumensin™ and V-Max®

Cattle/growing beef steers and heifers fed in confinement for slaughter

For the prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii, and reduction of incidence of liver abscesses in growing beef steers and heifers fed in confinement for slaughter.

Rumensin™ and V-Max®

Cattle/growing beef steers and heifers fed in confinement for slaughter

For improved feed efficiency and reduction of incidence of liver abscesses in growing beef steers and heifers fed in confinement for slaughter.

Rumensin™ and V-Max®

Laying Hen Replacement Chickens and Layer Breeder Replacement Chickens

To aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima in laying hen replacement chickens and layer breeder replacement chickens.

Do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses and guinea fowl has been fatal. Not for broiler breeder replacement chickens.

Coban™ 90

Broiler Chickens

As an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima and for increased rate of weight gain and improved feed efficiency in broiler chickens.

CobanTM and Albac®

Broiler Chickens

For increase in rate of weight gain, improved feed efficiency improved pigmentation, and as an aid in the prevention of coccidiosis caused by E. necatrix, E. tenella, E. acervulina, E. brunette, E. mivati, and E. maxima.

Do not feed to laying chickens. Feed continuously as the sole ration. Withdraw 5 days before slaughter. Sole source of organic arsenic. Must be thoroughly mixed in feeds before use. Do not feed undiluted. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Consumption by unapproved species may result in toxic reactions.

Coban® / Lincomix® / Roxarsone

Broiler Chickens

For increase in rate of weight gain; as an aid in the prevention of coccidiosis caused by E. necatrix, E. tenella, E. acervulina E. brunette, E. mivati, and E. maxima.

Do not feed to laying chickens. Feed continuously as the sole ration. Withdraw 5 days before slaughter. Sole source of organic arsenic. Must be thoroughly mixed in feeds before use. Do not feed undiluted. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Consumption by unapproved species may result in toxic reactions.

Coban® / Lincomix® / Roxarsone

Broiler Chickens

For improved feed efficiency; as an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. maxima, E. brunette and E. mivati

Do not feed to laying chickens. Feed continuously as the sole ration. Withdraw 5 days before slaughter. As sole source of organic arsenic. Do not allow horses or other equines access to formulations containing monensin. Ingestion of monensin by equines has been fatal. Do not allow horses or other equines access to formulations containing monensin. Ingestion of monensin by equines has been fatal. Must be thoroughly mixed in feeds before use. Do not feed undiluted.

3-Nitro® / Albac® / Coban®

Broiler Chickens

To aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima in broiler chickens.

Do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses and guinea fowl has been fatal. In the absence of coccidiosis in broiler chickens the use of monensin with no withdrawal period may limit feed intake resulting in reduced weight gain. Not for broiler breeder replacement chickens.

Coban™ 90

Chickens (broilers)

As an aid in the control of necrotic enteritis caused or complicated by Clostridium species or other organisms susceptible to bacitracin methylene disalicylate; as an aid in the prevention of coccidiosis caused by Eimeria tenella, E. necatrix, E. acervulina, E. maxima, E. brunetti, and E. mivati; for increased rate of weight gain and improved feed efficiency.

For broiler chickens only. Feed continuously as sole ration. Use as sole source of organic arsenic. Withdraw 5 days before slaughter. Do not feed to laying hens. To control necrotic enteritis, start medication at first clinical signs of disease. The dosage range permitted provides for different levels based on the severity of infection. Use continuously for 5 to 7 days or as long as clinical signs persist, then reduce dosage to prevention level. Animals should have access to drinking water at all times. Drug overdosage or lack of water may result in leg weakness. Do not allow horses or other equines access to formulations containing monensin. Ingestion of monensin by equines has been fatal.

3-Nitro® / BMD® / Coban®

Chickens (broilers)

As an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima; and for the control of complicated chronic respiratory disease (CRD or air-sac infection) caused by Mycoplasma gallisepticum and Escherichia coli in broiler chickens.

Feed continuously as sole ration. Withdraw 72 hours before slaughter. Do not feed to laying chickens. Do not feed to chickens over 16 weeks of age. Do not use in low-calcium feed containing less than 0.55% dietary calcium. Use in such feeds may result in violative residues. Do not allow horses other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses andguinea fowl has been fatal. In the absence of coccidiosis in broiler chickens, use of monensin with no withdrawal period may limit feed intake, resulting in reduced weight gain. Not for replacement chickens intended to become breeding chickens.

Coban™/TM®

Chickens (broilers)

As an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima; and as an aid in the reduction of mortality due to air-sacculitis (air-sac infection) caused by Escherichia coli sensitive to oxytetracycline in broiler chickens.

Feed for 5 days as the sole ration. Treat at first clinical signs of disease. Withdraw 72 hours before slaughter. Do not feed to laying chickens. Do not feed to chickens over 16 weeks of age. Do not use in low-calcium feed containing less than 0.55% dietary calcium. Use in such feeds may result in violative residues. Do not allow horses other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses and guinea fowl has been fatal. In the absence of cocciodiosis in broiler chickens, use of monensin with no withdrawal period may limit feed intake, resulting in reduced weight gain. Not for replacement chickens intended to become breeding chickens.

Coban™/TM®

Chickens (broilers)

For reduction of mortality due to Escherichia coli infections susceptible to chlortetracycline and as an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima in broiler chickens.

Pennchlor® and Coban™

Chickens (broilers)

For improved feed efficiency; for improved pigmentation by enhancing carotenoid and xanthophyll utilization; for the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. maxima, E. brunetti, and E. mivati.

Do not feed to laying chickens. Feed continuously as the sole ration. Withdraw 5 days before slaughter. As sole source of organic arsenic.

3-Nitro® / Albac® / Coban®

Chickens (broilers)

For increased rate of weight gain and improved feed efficiency; and as an aid in the prevention of coccidiosis caused by Eimera necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima.

Do not feed to laying chickens. Feed continuously as sole ration. In the absence of coccidiosis, the use of monensin with no withdrawal period may limit feed intake resulting in reduced weight gain.

Coban™ plus Baciferm®

Chickens (broilers)

As an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima; for increase in rate of weight gain and improved feed efficiency.

Do not feed to laying chickens. Feed continuously as sole ration. In the absence of coccidiosis, the use of monensin with no withdrawal period may limit feed intake in reduced weight gain.

Coban™ plus BMD®

Chickens (broilers)

Growth promotion and feed efficiency, improving pigmentation; as an aid in the prevention of coccidiosis caused by E. necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati and E. maxima.

Do not feed to laying chickens. Feed continuously as the sole ration. As sole source of organic arsenic. As monensin or monensin sodium. Labeling: The labeling of Type A articles containing monensin intended for use in chickens shall bear the following caution statements: Do not feed undiluted. Do not feed to laying chickens. Do not allow horses, other equines, mature turkeys or guinea fowl access to feed containing monensin. Ingestion of monensin by horses and guinea fowl has been fatal. In the absence of coccidiosis in broiler chickens the use of monensin with no withdrawal period may limit feed intake resulting in reduced weight gain.

Coban® plus 3-Nitro®

Chickens (broilers)

For increase in rate of weight gain; as an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. maxima, E. brunetti, and E. mivati.

Do not feed to laying chickens. Feed continuously as the sole ration. Withdraw 5 days before slaughter. As sole source of organic arsenic. As monensin sodium; as roxarsone. Do not allow horses or other equines access to formulations containing monensin. Ingestion of monensin by equines has been fatal.

3-Nitro® / Stafac® / Coban®

Chickens (broilers)

For improved feed efficiency and as an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. maxima and E. mivati .

Do not fed to laying chickens. Feed continuously as sole ration. In the absence of coccidiosis, the use of monensin with no withdrawal period may limit feed intake resulting in reduced weight gain. As monensin sodium.

Coban® / BMD®

Replacement Chicken

As an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima, as an aid in the prevention of necrotic enteritis caused or complicated by Clostridium spp. or other organisms susceptible to bacitracin, and for increased rate of weight gain, improved feed efficiency, and improved pigmentation in replacement chickens intended for use as cage layers.

Feed continuously as sole ration. For replacement chickens intended for use as cage layers only. Do not feed to laying chickens. Do not feed to chickens over 16 weeks of age. Do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses, mature turkeys, and guinea fowl has been fatal. Use as the sole source of organic arsenic. Poultry should have access to drinking water at all times. Drug overdosage or lack of water may result in leg weakness or paralysis.

3-Nitro® / BMD® / Coban®

Replacement Chicken

As an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima, and for increased rate of weight gain and improved feed efficiency in replacement chickens intended for use as cage layers.

Feed continuously as sole ration. For replacement chickens intended for use as cage layers only. Do not feed to laying chickens. Do not feed to chickens over 16 weeks of age. Do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses, mature turkeys, and guinea fowl has been fatal.

BMD® / Coban®

Replacement Chickens

As an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima, and for increased rate of weight gain, improved feed efficiency, and improved pigmentation in replacement chickens intended for use as cage layers.

Feed continuously as sole ration. For replacement chickens intended for use as cage layers only. Do not feed to laying chickens. Do not feed to chickens over 16 weeks of age. Do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses, mature turkeys, and guinea fowl has been fatal. Use as the sole source of organic arsenic. Poultry should have access to drinking water at all times. Drug overdosage or lack of water may result in leg weakness or paralysis.

3-Nitro® / Coban®

Broiler and Replacement Chickens

As an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima, and as an aid in the prevention of necrotic enteritis caused or complicated by Clostridium spp. or other organisms susceptible to bacitracin in broiler chickens and replacement chickens intended for use as cage layers.

Feed continuously as sole ration. For replacement chickens intended for use as cage layers only. Do not feed to laying chickens. Do not feed to chickens over 16 weeks of age. Do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses, mature turkeys, and guinea fowl has been fatal.

BMD® / Coban®

Broiler chickens

As an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima, and for the control of necrotic enteritis caused or complicated by Clostridium spp. or other organisms susceptible to lincomycin in broiler chickens up to 16 weeks of age. Not for use in laying hens, breeder chickens, or turkeys.

Coban™ and LINCOMIX®

Broiler chickens

For the prevention of mortality caused by necrotic enteritis associated with Clostridium perfringens; and as an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima, in broiler chickens.

Inteprity™ and Coxidin®

Broiler chickens

For reduction of mortality due to Escherichia coli infections susceptible to chlortetracycline and as an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima in broiler chickens.

ChlorMax® and Coban™

Broiler chickens

As an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima; and for increase in rate of weight gain and improved feed efficiency in broiler chickens.

Coxidin® and BMD®

Broiler chickens

For increased rate of weight gain and improved feed efficiency, and as an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima in broiler chickens.

Pennitracin MD® and Coban™

Chickens (Broiler)

For prevention of necrotic enteritis caused by Clostridium perfringens susceptible to virginiamycin and as an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima.

Feed continuously as the sole ration for broiler chickens. Do not feed to laying chickens. Do not administer to chickens producing eggs for human consumption. The use of monensin with no withdrawal period may limit feed intake reducing weight gain. Do not allow horses or other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses and guinea fowl has been fatal. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Stafac® and Coban™

Chickens (broiler)

For the prevention of mortality caused by necrotic enteritis associated with Clostridium perfringens; and as an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E.maxima in broiler chickens.

Feed this complete Type C medicated feed as the sole ration for 21 consecutive days. Feed to chickens that are at risk of developing, but not yet showing clinical signs of necrotic enteritis associated with Clostridium perfringens in broiler chickens. To assure responsible antimicrobial drug use in broiler chickens, treatment administration must begin on or before 18 days of age. The safety of avilamycin has not been established in chickens intended for breeding purposes. Avilamycin has not been demonstrated to be effective in broiler chickens showing clinical signs of necrotic enteritis prior to the start of medication. In the absence of coccidiosis in broiler chickens the use of monensin with no withdrawal period may limit feed intake resulting in reduced weight gain. Not for broiler breeder replacement chickens. Do not feed to laying chickens. Do not feed to chickens over 16 weeks of age. Do not allow horses,equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses and guinea fowl has been fatal.

Inteprity™ and Coban™

Laying hen replacement chickens and layer breeder replacement chickens

For the prevention of mortality caused by necrotic enteritis associated with Clostridium perfringens, and as an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima in laying hen replacement chickens and layer breeder replacement chickens.

Pennitracin MD® and Coban™

Laying hen replacement chickens and layer breeder replacement chickens

For increased rate of weight gain and improved feed efficiency, and as an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima in laying hen replacement chickens and layer breeder replacement chickens.

Pennitracin MD® and Coban™

Broiler Chickens, Laying Hen Replacement Chickens, and Layer Breeder Replacement Chickens:

As an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima.

Coxidin® 90

Growing Turkeys

For the prevention of coccidiosis caused by Eimeria adenoids, E. meleagrimitis, and E. gallopavonis, and as an aid in the control of transmissible enteritis complicated by organisms susceptible to bacitracin methylene disalicylate.

For growing turkeys only. Feed continuously as sole ration. Do not allow horses, other equines, mature turkeys or guinea fowl access to feed containing monensin. Ingestion of monensin by horses and guinea fowl has been fatal. Some strains of turkey coccidia may be monensin tolerant or resistant. Monensin may interfere with development of immunity to turkey coccidiosis.

BMD® / Coban®

Growing Turkeys

For the prevention of coccidiosis caused by Eimeria adenoeides, E. meleagrimitis, and E. gallopavonis, and for increased rate of weight gain and improved feed efficiency in growing turkeys.

For growing turkeys only. Feed continuously as sole ration. Do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses, mature turkeys, and guinea fowl has been fatal. Some strains of turkey coccidia may be monensin tolerant or resistant. Monensin may interfere with development of immunity to turkey coccidiosis. Do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses, mature turkeys, and guinea fowl has been fatal. Some strains of turkey coccidia may be monensin tolerant or resistant. Monensin may interfere with development of immunity to turkey coccidiosis.

Coban® / Stafac®

Growing Turkeys

For the prevention of coccidiosis in turkeys caused by E. adenoeides, E. meleagrimitis, and E. gallopavonis, and for improved feed efficiency in growing turkeys.

For growing turkeys only. Feed continuously as sole ration. Some strains of turkey coccidia may be monensin tolerant or resistant. Monensin may interfere with development of immunity to turkey coccidiosis. Do not allow horses or other equines access to formulations containing monensin. Ingestion of monensin by equines has been fatal. Must be thoroughly mixed in feeds before use. Do not feed undiluted.

Coban® / Flavomycin®

Growing Turkeys

For the prevention of coccidiosis in turkeys caused by Eimeria adenoeides, E. meleagrimitis, and E. gallopavonis.

Do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses and guinea fowl has been fatal. Some strains of turkey coccidia may be monensin tolerant or resistant. Monensin may interfere with development of immunity to turkey coccidiosis. Not for broiler breeder replacement chickens.

Coban™ 90

For increased rate of weight gain and improved feed efficiency in finishing hen turkeys fed for the last 7 to 14 days prior to slaughter, and for the prevention of coccidiosis in growing turkeys caused by Eimeria adenoeides, E. meleagrimitis and E. gallopavonis

Not for animals intended for breeding.

Topmax™ plus Coban®

Growing turkeys

For the prevention of coccidiosis caused by Eimeria adenoeides, E. meleagrimitis, and E. gallopavonis; and as an aid in the control for transmissible enteritis in growing turkeys complicated by organisms susceptible to bacitracin methylenedisalicylate.

Coxidin® and BMD®

Growing turkeys

For the prevention of coccidiosis caused by Eimeria adenoeides, E. meleagrimitis, and E. gallopavonis; and for increased rate of weight gain and improved feed efficiency in growing turkeys.

Coxidin® and BMD®

Growing turkeys

For increased rate of weight gain and improved feed efficiency, and for the prevention of coccidiosis caused by Eimeria adenoeides, E. meleagrimitis and E. gallopavonis in growing turkeys.

Pennitracin MD® and Coxidin®

Growing turkeys

For the prevention of coccidiosis caused by Eimeria adenoeides, E. meleagrimitis, and E. gallopavonis; and for improved feed efficiency in growing turkeys.

Coxidin® and Flavomycin®

Growing turkeys

For the prevention of coccidiosis caused by Eimeria adenoeides, E. meleagrimitis and E. gallopavonis

Pennitracin MD® and Coban™

Growing turkeys

For increased rate of weight gain and improved feed efficiency

Pennitracin MD® and Coban™

Goats maintained in confinement except reproducing or lactating goats

For the prevention of coccidiosis caused by Eimeria crandallis, Eimeria christenseni, and Eimeria ninakohlyakimovae.

Feed only to goats maintained in confinement. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Rumensin™ 90

Growing Bobwhite Quail

For the prevention of coccidiosis in growing Bobwhite quail caused by Eimeria dispersa and E. lettyae.

Do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses and guinea fowl has been fatal. Not for broiler breeder replacement chickens.

Coban™ 90

Please see NADA 125-476 for more information

Please see NADA 125-476 for more information

MGA® 100-200 / Rumensin®

Instrucciones de mezcla (Pollos de engorde y gallinas ponedoras de reemplazo y gallinas reproductoras ponedoras de reemplazo) - Mezclar completamente Coxidin 90 con una cantidad suficiente de alimento no medicamentoso para generar una tonelada de alimento para pollos que brinda entre 90 y 110 gramos de monensina por tonelada. Monensina (Gramos por tonelada) Coxidin 90 (Libras por tonelada de alimento de tipo C) 90 0.99 95 1.05 100 1.10 105 1.16 110 1.21 Instrucciones de administración - Alimentar de manera continua como ración única. Instrucciones de mezcla (Pavos) - Mezclar completamente las siguientes cantidades de Coxidin 90 con la cantidad suficiente de alimento no medicamentoso para obtener una tonelada completa de alimento para pavos que brinde de 54 a 90 gramos de monensina por tonelada. Monensina (Gramos por tonelada) Coxidin 90 (Libras por tonelada de alimento de tipo C) 54 0.60 66 0.73 78 0.86 90 0.99 Instrucciones de administración - Para pavos de crianza únicamente, alimentar de manera continua como ración única. El nivel óptimo depende de la gravedad de la exposición a coccidiosis. Instrucciones de mezcla (Codorniz) - Mezclar completamente las siguientes cantidades de Coxidin 90 con la cantidad suficiente de alimento no medicamentoso para obtener una tonelada completa de alimento para codornices que brinde 73 gramos de monensina por tonelada. Monensina (Gramos por tonelada) Coxidin 90 (Libras por tonelada de alimento de tipo C) 73 0.80 Instrucciones de administración - Para codornices, alimentar de manera continua como ración única. El alimento medicamentoso de tipo C debe tener una validez de 90 días desde la fecha de fabricación.

FDA application 200-783

Growing beef steers and heifers fed in confinement for slaughter: A. For improved feed efficiency. B. For the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii. Dairy cows: A. For increased milk production efficiency (production of marketable solids-corrected milk per unit of feed intake). Growing beef steers and heifers on pasture (stocker, feeder, and slaughter) or in a dry lot: A. For increased rate of weight gain. B. For the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii. Replacement beef and dairy heifers: A. For increased rate of weight gain. B. For the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii. Beef cows: A. For improved feed efficiency when receiving supplemental feed. B. For the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii. Goats maintained in confinement except reproducing or lactating goats: A. For the prevention of coccidiosis caused by Eimeria crandallis, Eimeria christenseni, and Eimeria ninakohlyakimovae. Calves (excluding veal calves): A. For the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii.

FDA application 200-639

Pollos de engorde de reemplazo y gallinas ponedoras de reemplazo y pollos reproductores ponedores de reemplazo: Como ayuda para prevenir la coccidiosis provocada por Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, y E. maxima. Pavos: Para la prevención de coccidiosis en pavos causada por Eimeria adenoeides, E. meleagrimitis y E. gallopavonis. Codornices: Para la prevención de coccidiosis en codornices de crianza causadas por Eimeria dispersa y E. lettyae. Importante: Debe mezclarse bien con los alimentos antes de usar. Mezclar completamente Coxidin 90 con una pequeña cantidad de alimento no medicamentoso (p. ej., 1 lb con 100-200 lb) antes de la incorporación en el alimento medicamentoso de Tipo C.

FDA application 200-783

Broiler and Laying Hen Replacement Chicken and Layer Breeder Replacement Chicken: As an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima. Turkeys: For the prevention of coccidiosis in turkeys caused by Eimeria adenoeides, E. meleagrimitis and E. gallopavonis. Quail: For the prevention of coccidiosis in growing Bobwhite quail caused by Eimeria dispersa and E. lettyae. Important: Must be thoroughly mixed in feeds before use. Mix thoroughly Coxidin 90 with a small quantity of non-medicated feed (e.g., 1 lb with 100-200 lb) before incorporation into the Type C medicated feed.

FDA application 200-783

Mixing Directions (Broiler Chickens, Laying Hen Replacement Chickens, and Layer Breeder Replacement Chickens) – Thoroughly mix the following amounts of Coxidin 90 with a sufficient quantity of unmedicated feed to make one ton of complete chicken feed to provide 90 through 110 grams monensin per ton. Monensin (Grams Per Ton) Coxidin 90 (Lbs Per Ton of Type C Feed) 90 0.99 95 1.05 100 1.10 105 1.16 110 1.21 Feeding Directions – Feed continuously as the sole ration.

FDA application 200-783

Mixing Directions (Turkeys) – Thoroughly mix the following amounts of Coxidin 90 with a sufficient quantity of unmedicated feed to make one ton of complete turkey feed to provide 54 through 90 grams monensin per ton. Monensin (Grams Per Ton) Coxidin 90 (Lbs Per Ton of Type C Feed) 54 0.60 66 0.73 78 0.86 90 0.99 Feeding Directions – For growing turkeys only, feed continuously as the sole ration. The optimum level depends upon the severity of coccidiosis exposure.

FDA application 200-783

Mixing Directions (Bobwhite Quail) – Thoroughly mix the following amounts of Coxidin 90 with a sufficient quantity of unmedicated feed to make one ton of complete quail feed to provide 73 grams monensin per ton. Monensin (Grams Per Ton) Coxidin 90 (Lbs Per Ton of Type C Feed) 73 0.80 Feeding Directions – For Bobwhite quail, feed continuously as the sole ration. The Type C medicated feed must bear an expiry of 90 days from the date of manufacture.

FDA application 200-783

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes and suppression of estrus (heat) in heifers fed in confinement for slaughter for the last 20 to 40 days on feed.

Feed continuously as sole ration during the last 20 to 40 days on feed. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Zilpaterol hydrochloride is not for use in animals intended for breeding. Do not allow horses or other equines access to feed containing zilpaterol. Do not use in veal calves. Not to be fed to cattle in excess of 90 mg/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90 percent dry matter basis), zilpaterol should not be fed in complete feed. Animals receiving zilpaterol hydrochloride may exhibit increased respiratory rate as well as elevated levels of creatine phosphokinase (CPK) and creatine. Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days or more should be avoided to prevent the possibility that the heifers may come into estrus (heat) at loading time. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian. Special considerations: 1) For liquid melengestrol acetate Type C feeds stored in recirculation tank systems, labeling indicates: “Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents from the bottom of the tank to the top. Recirculate daily, as directed in this paragraph even when the Type C feed is not used.” For liquid melengestrol Type C feeds stored in mechanical, air or other agitation-type tank systems: “Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily, as directed in this paragraph, even when the Type C feed is not used.” 2) All labeling for Type C feeds containing zilpaterol hydrochloride provides the warning: The active ingredient in Zilmax® is zilpaterol hydrochloride, a beta2-adrenergic agonist. Not for use in humans. An anti-dust process has been applied to the drug product, Zilmax®, in order to greatly reduce inhalation risk. Extended handling tasks with the potential for dust generation require respiratory protection. Wear appropriate skin protection (e.g., impervious gloves, apron, overalls), if there is a potential for extended skin contact. Wear protective eyewear, if there is a potential for eye contact. If accidental eye contact occurs, immediately rinse with water and consult a physician.

Zilmax®/Rumensin®/Tylovet® 100/MGA®

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and prevention and control of coccidiosis due to Eimeria bovis and E. zuernii in cattle fed in confinement for slaughter during the last 28 to 42 days on feed.

Feed continuously as sole ration for the last 28 to 42 days on ration. Not for animals intended for breeding. Do not use in calves to be processed for veal. Ractopamine hydrochloride top dress (not to exceed 800g/ton) plus monensin USP (10 to 40 g/ton).

Actogain™ 45 plus Rumensin®

Pollos de engorde de reemplazo y gallinas ponedoras de reemplazo y pollos reproductores ponedores de reemplazo: Como ayuda para prevenir la coccidiosis provocada por Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, y E. maxima.

FDA application 038-878

La mezcla inadecuada (recirculación o agitación) de alimentos medicados de tipo B o de tipo C líquidos con monensina produjo un aumento de la concentración de monensina que fue mortal para el ganado y que podría serlo también para las cabras. • Si los alimentos rechazados con monensina se ofrecen a otros grupos de ganado, la concentración de monensina en dichos alimentos y la cantidad de estos deben tenerse en cuenta a fin de evitar sobredosis de monensina. Instrucciones de uso: Lea atentamente todas las instrucciones antes de mezclar y ofrecer como alimento Tabla 1: Instrucciones de mezcla para alimentos de ganado (sin incluir las vacas lecheras), cabras y terneros a base de materia seca del 90 % Concentración deseada de monensina en alimentos medicadosa Cantidad de Rumensin 90 necesaria por tonelada gramos/tonelada mg/libra de alimento libras gramos 5 2.5 0.06 25.00 20 10 0.22 100.02 30 15 0.33 150.03 40 20 0.44 200.04 400 200 4.41 2000.40 1200 600 13.23 6001.19 Tabla 2: Instrucciones de mezcla para raciones combinadas totales (total mixed rations, TMR) en vacas lecherasa aLa cantidad de tipo B (base alimentaria) necesaria para producir TMR con un nivel deseado de monensina es la siguiente: ((Nivel deseado de monensina en TMR g/tonelada) X (% materia seca de TMR)/g/tonelada de monensina en tipo B) X 2000 Ejemplo de dieta: Deseada de 11 g/tonelada de monensina en TMR (base de materia seca); las TMR contienen 50 % de materia seca, y el tipo B contiene 500 g/tonelada de monensina. Ejemplo de solución: ((11 g/tonelada) X (0.50 materia seca de TMR)/500 g/tonelada de monensina en el tipo B) X 2000 = 22 libras de tipo B necesarias por tonelada de TMR b(Concentración deseada de monensina en alimento de tipo B, g/tonelada)/90.7 g/libra. Ejemplo: 500 g/tonelada /90.7 g/libra = 5.51 libra Rumensin 90 por tonelada de tipo B cSe recomienda que los alimentos de tipo B que contengan más de 1440 g/tonelada continúen diluyéndose antes de mezclar con las TMR. Un ejemplo de dilución adicional sería una proporción de 1:10 de alimento medicado de tipo B: Alimento no medicado. dbase de materia seca del 100 % Cantidad de Rumensin 90 necesaria por tonelada de tipo B, libra b Concentración deseada de monensina en alimento de tipo B, g/tonelada; base alimentaria c Materia seca de las TMR,% Concentración deseada de monensina, g/tonelada en TMR d 11 15 22 libra de tipo B (base alimentaria) necesaria por tonelada de TMR 5.51 500 50 60 22.00 26.40 30.00 36.00 44.00 52.80 15.88 1440 50 60 7.64 9.17 10.42 12.50 15.28 18.33 88.20 8000 50 60 1.38 1.65 1.88 2.25 2.75 3.30 Tabla 3: Instrucciones de mezcla para vacas lecheras en sistemas de alimentación por componente (incluso agregados)a a La cantidad de tipo B (base alimentaria) necesaria para producir la porción por componente de la ración con un nivel deseado de monensina es la siguiente: (Nivel deseado de monensina en componente, g/tonelada/g/tonelada de monensina en tipo B) X 2000 Ejemplo de agregado: Ideal de 50 g/tonelada de monensina en el componente, y el tipo B contiene 500 g/tonelada de monensina. Ejemplo de solución: (50 g/tonelada/500 g/tonelada de monensina en el tipo B) X 2000 = 200 libras de tipo B necesarias por tonelada de agregado b (Concentración deseada de monensina en alimento de tipo B, g/tonelada)/90.7 g/libra. Ejemplo: 500 g/tonelada/90.7 g/libra = 5.51 libra Rumensin 90 por tonelada de tipo B c Se recomienda que los alimentos de tipo B que contengan más de 1440 g/tonelada continúen diluyéndose antes de mezclar con el agregado. Un ejemplo de dilución adicional sería una proporción de 1:10 de alimento medicado de tipo B: Alimento no medicado. Cantidad de Rumensin 90 necesaria por tonelada de tipo B, libra b Concentración deseada de monensina en alimento de tipo B, g/tonelada; base alimentaria c Concentración deseada de monensina, g/tonelada en alimentación por componente 50 200 400 libra de tipo B (base alimentaria) necesaria por tonelada de alimentación por componente 5.51 500 200.00 800.00 1600.00 18.74 1700 58.82 235.29 470.59 44.10 4000 25.00 100.00 200.00 88.20 8000 12.50 50.00 100.00 BG103077B PRINTED WITH SOY INK TÓMESE SU TIEMPO SIGA LAS INSTRUCCIONES DEL PROSPECTO

FDA application 095-735

NOT FOR HUMAN USE WARNING: A withdrawal time has not been established for pre-ruminating calves. Do not use in calves to be processed for veal. When mixing and handling Monovet 90, use protective clothing, impervious gloves and a dust mask. Operators should wash thoroughly with soap and water after handling. If accidental eye contact occurs, immediately rinse with water. To report suspected adverse drug events, for technical assistance or to obtain a copy of the Safety Data Sheet (SDS), contact Huvepharma, Inc. at 1-877-994-4883 or www.huvepharma.us. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or http://www.fda.gov/reportanimalae. Store at or below 25°C (77°F). Excursions permitted to 37°C (99°F). Not to be used after date printed on gusset of bag. Restricted Drug (California) - Use Only as Directed Approved by FDA under ANADA # 200-639 Huvepharma and Monovet are registered trademarks of Huvepharma EOOD. Distributed by Huvepharma Inc., Peachtree City, GA 30269, USA

FDA application 200-639

No se determinó un tiempo de retiro para los terneros prerrumiantes. No usar en terneros que se procesarán para carnear. Al mezclar y al manipular Rumensin 90, usar ropa protectora, guantes impermeables y una máscara antipolvo. Los operadores deben lavarse bien con agua y jabón luego de manipular el producto. Si se produce contacto accidental con los ojos, enjuague inmediatamente con agua. Para informar sobre efectos adversos, acceder a información médica u obtener más información sobre el producto, llame al 1-800-428-4441. Almacenar a una temperatura igual o inferior a 25 °C (77 °F). Se permiten desviaciones de hasta 37 °C (99 °F). No debe usarse después de la fecha impresa en la bolsa. Fármaco restringido (California). Usar únicamente según las instrucciones. Aprobado por la FDA bajo NADA # 095-735. Rumensin, Elanco y el logo de la barra diagonal son marcas de Elanco o sus afiliadas. © 2021 Elanco or its affiliates. Elanco US, Inc., Greenfield, IN 46140 EE. UU.

FDA application 095-735

A withdrawal time has not been established for pre-ruminating calves. Do not use in calves to be processed for veal. When mixing and handling Rumensin 90, use protective clothing, impervious gloves and a dust mask. Operators should wash thoroughly with soap and water after handling. If accidental eye contact occurs, immediately rinse with water. To report adverse effects, access medical information, or obtain additional product information, call 1-800-428-4441. Store at or below 25°C (77°F). Excursions permitted to 37°C (99°F). Not to be used after date printed on bag. Restricted Drug (California) - Use Only as Directed Approved by FDA under NADA # 095-735 Rumensin, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. © 2021 Elanco or its affiliates. Manufactured for: Elanco US, Inc., Greenfield, IN 46140, USA

FDA application 095-735

NOT FOR HUMAN USE Warning Withdrawal Period: No withdrawal period is required when used according to labeling. User Safety Warning: When mixing and handling Coban 90, use protective clothing, impervious gloves, and a dust mask. Operators should wash thoroughly with soap and water after handling. If accidental eye contact occurs, immediately rinse thoroughly with water.

FDA application 038-878

Advertencias de seguridad para el usuario: Al mezclar y al manipular Coxidin 90, usar ropa protectora, guantes impermeables y una máscara antipolvo. Los operadores deben lavarse bien con agua y jabón luego de manipular el producto. Si se produce contacto accidental con los ojos, enjuague inmediatamente con agua.

FDA application 200-783

User Safety Warning: When mixing and handling Coxidin 90, use protective clothing, impervious gloves, and a dust mask. Operators should wash thoroughly with soap and water after handling. If accidental eye contact occurs, immediately rinse thoroughly with water.

FDA application 200-783

NO USAR EN SERES HUMANOS Advertencia Tiempos de espera: No es necesario un tiempo de espera cuando se usa de acuerdo con las indicaciones de la etiqueta.

FDA application 200-783

NOT FOR HUMAN USE Warning Withdrawal Period: No withdrawal period is required when used according to labeling.

FDA application 200-783

NO USAR EN SERES HUMANOS Advertencia

FDA application 038-878

¿Preguntas/Comentarios? Para informar sobre efectos secundarios, acceder a información médica u obtener más información sobre el producto, llame a Huvepharma, Inc. al 1-877-994-4883. Para información adicional sobre cómo denunciar efectos secundarios de drogas para animales, contacte al FDA al 1-888-FDA-VETS o visite http://www.fda.gov/reportanimalae COXIDIN es una marca registiada de Huvepharma EOOD.

FDA application 200-783

Questions/Comments? To report side effects, access medical information, or obtain additional product information, call Huvepharma, Inc. at 1-877-994-4883. For additional information about reporting side effects for animal drugs, contact FDA at 1-888-FDA-VETS or http://www.fda.gov/reportanimalae COXIDIN is a registered trademark of Huvepharma EOOD.

FDA application 200-783

Cattle (heifers fed in confinement for slaughter)

Melengestrol acetate, 0.25 to 0.50 milligram per head per day, plus monensin (as monensin sodium) at 50 to 360 milligrams per head per day, plus tylosin (as tylosin phosphate), 90 milligrams per head per day. To attain these amounts: Add 0.5 to 2.0 pounds per head per day of a liquid or dry medicated feed containing 0.125 to 1.0 milligram of melengestrol acetate per pound to a medicated feed containing 5 to 30 grams of monensin and 8 to 10 grams of tylosin per ton; or; Add 0.5 to 2.0 pounds per head per day of a liquid or dry medicated feed containing 0.125 to 1.0 milligram of melengestrol acetate plus 25 to 720 milligrams of monensin per pound to 4.5 to 18 pounds of a dry medicated feed containing 10 to 40 grams of tylosin per ton; or; Add 0.5 to 2.0 pounds per head per day of a dry medicated feed containing 0.125 to 1.0 milligram of melengestrol acetate (from a dry Type A article), 25 to 600 milligrams of monensin, plus 45 to 180 milligrams of tylosin per pound to a ration of non-medicated feed.

Oral

For heifers fed in confinement for slaughter.

MGA® 100 / Rumensin® / Tylan®

Cattle (heifers fed in confinement for slaughter)

Feed continuously as sole rotation containing 9.8 to 24.6 grams/ton ractopamine to provide 90 to 430 mg/hd/day ractopamine; combined with monensin 10 to 40 grams per ton to provide 0.14 to 0.42 mg monensin/lb of body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day; tylosin 8 to 10 grams per ton to provide 60 to 90 mg/head/day tylosin for the last 28 to 42 days on feed. Mix or top dress with medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound fed at the rate of 0.5 to 2.0 lb/head/day to provide 0.25 to 0.5 milligrams per head per day for the last 28 to 42 days on feed.

Oral

Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at time of loading. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Ractopamine HCl is not for animals intended for breeding. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian. Special considerations: Mixing directions for liquid melengestrol acetate Type C feeds storedin recirculation tank systems, labeling indicates: “Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents from the bottom of the tankto the top. Recirculate daily, as directed in this paragraph evenwhen the Type C feed is not used." For liquid melengestrol Type C feeds stored in mechanical, air or other agitation-type tank systems:“Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily, as directed in this paragraph, even when the Type C feed is not used.”

Heifermax™ / Optaflexx® / Rumensin® / Tylan®

Cattle (heifers fed in confinement for slaughter)

Complete feed: Feed continuously as sole ration containing 9.8 to 24.6 g/ton ractopamine to provide 90 to 430 mg/hd/day ractopamine; 10 to 40 g/ton monensin to provide 0.14 to 0.42 mg monensin/lb of body weight per day, depending on severity of coccidiosis challenge, up to 480 mg/head/day; 8 to 10 g/ton tylosin to provide 60 to 90 mg/head/day tylosin for the last 28 to 42 days on feed. Mix or top dress with medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound fed at the rate of 0.5 to 2.0 lb/head/day to provide 0.25 to 0.5 mg melengestrol acetate per head per day for the last 28 to 42 days on feed.

Oral

Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at time of loading. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Ractopamine HCl is not for animals intended for breeding.Special considerations:Mixing directions for liquid melengestrol acetate Type C feeds stored in recirculation tank systems, labeling indicates: “Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents from the bottom of the tank to the top. Recirculate daily, as directed in this paragraph even when the Type C feed is not used.” For liquid melengestrol Type C feeds stored in mechanical, air or other agitation-type tank systems: “Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily, as directed in this paragraph, even when the Type C feed is not used.”

Optaflexx™ and Rumensin™ and Tylan™and MGA®

Cattle (heifers fed in confinement for slaughter)

Component Feed: 6.8 to 24 g/ton zilpaterol to provide 60 mg/head/day zilpaterol; 10 to 40 g/ton monensin, to provide 0.14 to 0.42 mg/lb body weight/day monensin, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day monensin; and 8 to 10 g/ton tylosin to provide 60 to 90 mg/head/day tylosin; mixed or top dressed with medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound fed at the rate of 0.5 to 2.0 lb/head/day to provide 0.25 to 0.5 mg melengestrol acetate/head/day.

Oral

Feed continuously to cattle during the last 20 to 40 dayson feed. Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Zilpaterol hydrochloride is not for use in animals intended for breeding. Do not allow horses or other equines access to feed containing zilpaterol. Do not use in veal calves. Animals receiving zilpaterol hydrochloride may exhibit increased respiratory rate as well as elevated levels of creatine phosphokinase (CPK) and creatine. Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days or more should be avoided to prevent the possibility that the heifers may come into estrus (heat) at loading time. Special considerations:1) For liquid melengestrol acetate Type C feeds stored in recirculation tank systems, labeling indicates: “Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents from the bottom of the tank to the top. Recirculate daily, as directed in this paragraph even when the Type C feed is not used.” For liquid melengestrol Type C feeds stored in mechanical, air or other agitation-type tank systems: “Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily, as directed in this paragraph, even when the Type C feed is not used.”2) All labeling for Type C feeds containing zilpaterol hydrochloride provides the warning: The active ingredient in Zilmax® is zilpaterol hydrochloride, a beta2-adrenergic agonist. Not for use in humans. An anti-dust process has been applied to the drug product, Zilmax®, in order to greatly reduce inhalation risk. Extended handling tasks with the potential for dust generation require respiratory protection. Wear appropriate skin protection (e.g., impervious gloves, apron, overalls), if there is a potential for extended skin contact. Wear protective eyewear, if there is a potential for eye contact. If accidental eye contact occurs, immediately rinse with water and consult a physician.

Zilmax® and Rumensin™ and Tylan™ and MGA®

Cattle (heifers fed in confinement for slaughter)

Melengestrol acetate (0.125 to 1.0 mg/lb) is top dressed or mixed with a complete ration containing monensin (10-40 g/ton) and zilpaterol (6.8 g/ton).

Oral

Feed as the sole ration for the final 20 to 40 days. Do not use in calves to be processed for veal. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Zilpaterol hydrochloride is not for use in animals intended for breeding. Do not allow horses or other equines access to feed containing zilpaterol. Do not use in veal calves. Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90% dry matter basis), zilpaterol should not be fed in complete feed. Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days or more should be avoided to prevent the possibility that the heifers may come into estrus (heat) at loading time.

Heifermax® 500/Zilmax®/Rumensin®

Cattle (heifers fed in confinement for slaughter)

Melengestrol acetate (0.25 to 2 g/ton) in combination with monensin (10 to 40 g/ton) and tylosin (8 to 10 g/ton).

Oral

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian. Feed continuously as sole ration to heifers at a rate of 0.5 to 2.0 pounds per head per day to provide 0.25 to 0.5 mg/head/day melengestrol acetate and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day and 60 to 90 mg/head/day tylosin. The melengestrol acetate portion of this Type C medicated feed must be mixed into the complete feed containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin at feeding into the amount of complete feed consumed by an animal per day. Melengestrol acetate is for use only in heifers being fed in confinement for slaughter. Not effective in steers or spayed heifers. Heifers fed in confinement for slaughter: Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at the time of loading. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.

HeifermaX™ 500 / Rumensin™ / Tylan™

Cattle (Fed in Confinement for Slaughter)

Component Feed: Feed continuously to cattle during the last 20 to 40 days on feed, in a component feed containing 6.8 to 24 g/ton zilpaterol hydrochloride to provide 60 mg/head/day zilpaterol hydrochloride, In combination with: monensin, USP - 10 to 40 g/ton of feed to provide 0.14 to 0.42 mg monensin/lb of body weight, depending on severity of coccidiosis challenge, up to 480 mg/head/day

Oral

Feed continuously during the last 20 to 40 days on feed. Special considerations: 1) Labeling of Type C cattle feeds shall bear the following: (i) Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. (ii) Zilpaterol hydrochloride is not for use in animals intended for breeding. (iii) Do not allow horses or other equines access to feed containing zilpaterol. (iv) Do not use in veal calves. 2) Labeling of Type C complete feeds must bear the following caution statement: CAUTION: Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90% dry matter basis), zilpaterol should not be fed in complete feed.

Zilmax®/Rumensin®/MGA®

Cattle (Fed in Confinement for Slaughter)

Complete feed: Feed continuously to cattle during the last 20 to 40 days on feed as the sole ration, containing 6.8 g/ton zilpaterol to provide 60 to 90 mg zilpaterol hydrochloride per head per day, In combination with: monensin, USP - 10 to 40 g/ton of feed to provide 0.14 to 0.42 mg monensin/lb of body weight, depending on severity of coccidiosis challenge, up to 480 mg/head/day

Oral

Feed continuously during the last 20 to 40 days on feed. Special considerations: 1) Labeling of Type C cattle feeds shall bear the following: (i) Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. (ii) Zilpaterol hydrochloride is not for use in animals intended for breeding. (iii) Do not allow horses or other equines access to feed containing zilpaterol. (iv) Do not use in veal calves. 2) Labeling of Type C complete feeds must bear the following caution statement: CAUTION: Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90% dry matter basis), zilpaterol should not be fed in complete feed.

Zilmax®/Rumensin®/MGA®

Cattle (Fed in Confinement for Slaughter)

Component Feed: 6.8 to 24 g/ton zilpaterol hydrochloride to provide 60 mg/head/day zilpaterol hydrochloride during the last 20 to 40 days on feed, In combination with: monensin, USP- 10 to 40 g/ton monensin

Oral

Feed continuously during the last 20 to 40 days on feed. Special considerations: 1) Labeling of Type B and Type C cattle feeds shall bear the following: (i) Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thoroughly mixed in feeds before use. Do not feed undiluted. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. (ii) Zilpaterol hydrochloride is not for use in animals intended for breeding. (iii) Do not allow horses or other equines access to feed containing zilpaterol. (iv) Do not use in veal calves. 2) Labeling for Type B feeds used to manufacture Type C complete feeds must bear the caution statement: CAUTION: Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90% dry matter basis), zilpaterol should not be fed in complete feed. 3) Labeling of Type C complete feeds must bear the following caution statement: CAUTION: Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90% dry matter basis), zilpaterol should not be fed in complete feed. 4) Type B Liquid Feeds can be manufactured containing 68 to 680 g zilpaterol hydrochloride/ton. The liquid Type B feeds must be maintained at a pH of 4.3 to 7.1. For liquid feeds stored in recirculating tank systems: Recirculate immediately prior to use for not less than 10 minutes, moving not less than 1 percent of the tank contents per minute from the bottom of the tank to the top. Recirculate daily as described even when not used. For liquid feeds stored in mechanical, air or other agitation-type tank systems: Agitate immediately prior to use for not less than 10 minutes, creating turbulence at the bottom of the tank that is visible at the top. Agitate daily as described even when not used.

Zilmax® plus Rumensin®

Cattle (Fed in Confinement for Slaughter)

6.8 g/ton zilpaterol hydrochloride to provide 60 to 90 mg/head/per day zilpaterol hydrochloride during the last 20 to 40 days on feed,In combination with: monensin, USP- 10 to 40 g/ton monensin

Oral

Feed continuously during the last 20 to 40 days on feed. Special considerations: 1) Labeling of Type B and Type C cattle feeds shall bear the following: (i) Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thoroughly mixed in feeds before use. Do not feed undiluted. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. (ii) Zilpaterol hydrochloride is not for use in animals intended for breeding. (iii) Do not allow horses or other equines access to feed containing zilpaterol. (iv) Do not use in veal calves. 2) Labeling for Type B feeds used to manufacture Type C complete feeds must bear the caution statement: CAUTION: Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90% dry matter basis), zilpaterol should not be fed in complete feed. 3) Labeling of Type C complete feeds must bear the following caution statement: CAUTION: Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90% dry matter basis), zilpaterol should not be fed in complete feed. 4) Type B Liquid Feeds can be manufactured containing 68 to 680 g zilpaterol hydrochloride/ton. The liquid Type B feeds must be maintained at a pH of 4.3 to 7.1. For liquid feeds stored in recirculating tank systems: Recirculate immediately prior to use for not less than 10 minutes, moving not less than 1 percent of the tank contents per minute from the bottom of the tank to the top. Recirculate daily as described even when not used. For liquid feeds stored in mechanical, air or other agitation-type tank systems: Agitate immediately prior to use for not less than 10 minutes, creating turbulence at the bottom of the tank that is visible at the top. Agitate daily as described even when not used.

Zilmax® plus Rumensin®

Cattle (Heifers Fed in Confinement for Slaughter)

Component Feed: Feed continuously to cattle during the last 20 to 40 days on feed, in a component feed containing 6.8 to 24 g/ton zilpaterol hydrochloride to provide 60 mg/head/day zilpaterol hydrochloride, In combination with: monensin, USP - 10 to 40 g/ton of feed , and melengestrol acetate 0.5 to 2.0 lb/head/day of a feed containing 0.125 to 1.0 mg melengestrol acetate per pound to provide 0.25 to 0.5 mg melengestrol acetate/head/day. Feed melengestrol acetate in this combination during the last 20 to 40 days on feed.

Oral

Feed continuously during the last 20 to 40 days on feed. Special considerations: 1) Labeling of Type C cattle feeds shall bear the following: (i) Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. (ii) Zilpaterol hydrochloride is not for use in animals intended for breeding. (iii) Do not allow horses or other equines access to feed containing zilpaterol. (iv) Do not use in veal calves. 2) Labeling of Type C complete feeds must bear the following caution statement: CAUTION: Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90% dry matter basis), zilpaterol should not be fed in complete feed. 3) Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days or more should be avoided to prevent the possibility that the heifers may come into estrus (heat) at loading time.

Zilmax®/Rumensin®/MGA®

Cattle (Heifers Fed in Confinement for Slaughter)

Complete feed: Feed continuously to cattle during the last 20 to 40 days on feed as the sole ration, containing 6.8 g/ton zilpaterol to provide 60 to 90 mg zilpaterol hydrochloride per head per day, monensin, USP - 10 to 40 g/ton of feed, and melengestrol acetate 0.5 to 2.0 lb/head/day of a feed containing 0.125 to 1.0 mg melengestrol acetate per pound to provide 0.25 to 0.5 mg melengestrol acetate/head/day. Feed melengestrol acetate in this combination during the last 20 to 40 days on feed.

Oral

Feed continuously during the last 20 to 40 days on feed. Special considerations: 1) Labeling of Type C cattle feeds shall bear the following: (i) Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. (ii) Zilpaterol hydrochloride is not for use in animals intended for breeding. (iii) Do not allow horses or other equines access to feed containing zilpaterol. (iv) Do not use in veal calves. 2) Labeling of Type C complete feeds must bear the following caution statement: CAUTION: Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90% dry matter basis), zilpaterol should not be fed in complete feed. 3) Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days or more should be avoided to prevent the possibility that the heifers may come into estrus (heat) at loading time.

Zilmax®/Rumensin®/MGA®

Cattle (beef heifers fed in confinement for slaughter)

Melengestrol acetate (0.125 to 1.0 mg/lb) is top dressed or mixed with a complete ration containing monensin (10-40 g/ton) and ractopamine (9.8 to 24.6 g/ton).

Oral

Feed continuously as sole ration during the last 28 to 42 days on feed. Not for animals intended for breeding. Do not use in calves to be processed for veal.

Heifermax 500®/Optaflexx®/Rumensin®

Cattle (fed in confinement for slaughter)

Component Feed: 6.8 to 24 g/ton zilpaterol to provide 60 mg/head/day zilpaterol; 10 to 40 g/ton monensin, to provide 0.14 to 0.42 mg/lb body weight/day monensin, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day monensin; and 8 to 10 g/ton tylosin to provide 60 to 90 mg/head/day tylosin.

Oral

Feed continuously during the last 20 to 40 days on feed. Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.Zilpaterol hydrochloride is not for use in animals intended for breeding. Do not allow horses or other equines access to feed containing zilpaterol. Do not use in veal calves. Animals receiving zilpaterol hydrochloride may exhibit increased respiratory rate aswell as elevated levels of creatine phosphokinase (CPK) and creatine.Special considerations:1) Labeling for Type B feeds used to manufacture Type C complete feeds must bear the caution statement: Not to be fed to cattle in excess of 90 mg/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90 percent dry matter basis), zilpaterol should not be fed in complete feed. 2) Type B Liquid Feeds can be manufactured containing 68 to 680 g zilpaterol hydrochloride/ton. Inadequate mixing (recirculation or agitation) of monensin liquid Type B or Type C medicated feeds has resulted in increased monensin concentration, which has been fatal to cattle. For liquid feeds stored in recirculating tank systems: Recirculate immediately prior to use for not less than 10 minutes, moving not less than 1 percent of the tank contents per minute from the bottom of the tank to the top. Recirculate daily as described even when not used. For liquid feeds stored in mechanical, air or other agitation-type tank systems: Agitate immediately prior to use for not less than 10 minutes, creating turbulence at the bottom of the tank that is visible at the top. Agitate daily as described even when not used.3) All labeling for Type B and Type C feeds provides the warning: The active ingredient in Zilmax® is zilpaterol hydrochloride, a beta2-adrenergic agonist. Not for use in humans. An anti-dust process has been applied to the drug product, Zilmax®, in order to greatly reduce inhalation risk. Extended handling tasks with the potential for dust generation require respiratory protection. Wear appropriate skin protection (e.g., impervious gloves, apron, overalls), if there is a potential for extended skin contact. Wear protective eyewear, if there is a potential for eye contact. If accidental eye contact occurs, immediately rinse with water and consult a physician.

Zilmax® and Rumensin™ and Tylan™

Cattle (fed in confinement for slaughter)

Complete feed: 6.8 g/ton zilpaterol to provide 60 to 90 mg/head/day zilpaterol; 10 to 40 g/ton monensin, to provide 0.14 to 0.42 mg/lb body weight/day monensin, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day monensin; and 8 to 10 g/ton tylosin to provide 60 to 90 mg/head/day tylosin.

Oral

Feed continuously as sole ration during the last 20 to 40 days on feed. Do not allow horses or other equines access to feedscontaining monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.Zilpaterol hydrochloride is not for use in animals intended for breeding. Do not allow horses or other equines access to feed containing zilpaterol. Do not use in veal calves. Not to be fed to cattle in excess of 90 mg/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90 percent dry matter basis), zilpaterol should not be fed in complete feed. Animals receiving zilpaterol hydrochloride may exhibit increased respiratory rate as well as elevated levels of creatine phosphokinase (CPK) and creatine.

Zilmax® and Rumensin™ and Tylan™

Cattle (growing beef heifers fed in confinement for slaughter)

0.25 to 2 g/ton of melengestrol acetate (as HeifermaX™) to provide 0.25 to 0.5 mg melengestrol acetate per head per day and 10 to 40 g/ton of monensin (as Rumensin™) to provide 0.14 to 0.42 mg monensin per pound of body weight per day, depending upon severity of challenge, up to a maximum of 480 mg monensin per head per day. The melengestrol acetate Type C top-dress medicated feed (0.5 to 2 lb(s) per head per day) must be top dressed onto or mixed at feeding with a Type C medicated feed containing monensin.

Oral

HeifermaX™ and Rumensin™

Cattle fed in confinement for slaughter

Monensin is added to feedlot cattle diets at concentrations of 10 to 40 g of monensin USP per ton of complete feed at a rate of 0.14 to 0.42 mg monensin/lb of body weight, depending on severity of coccidiosis challenge, up to 480 mg monensin/head/day.Monensin is added to feedlot cattle diets at concentrations of 5 to 40 g of monensin USP per ton of complete feed for improved feed efficiency to provide 50 to 480 mg monensin/head/day.Tylosin is added to the cattle diets at concentrations of 8 to 10 g of tylosin phosphate per ton of complete feed to provide 60 to 90 mg tylosin/head/day.

Oral

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Rumensin® plus Tylovet® 100

Cattle fed in confinement for slaughter

568 to 757 g/ton of Pulmotil™ and 10 to 40 g/ton of Monovet®. To be fed continuously as the sole ration for a single, 14 day period at 568 grams to 757 grams tilmicosin per ton on a 100% dry matter basis (511.2 to 681.3 g per ton on a 90% dry matter basis) to provide 12.5 mg tilmicosin/kg of body weight/day and 10 grams to 40 grams monensin per ton on a 90% dry matter basis (11.1 to 44.4 g per ton on a 100% dry matter basis) to provide 0.14 to 0.42 mg monensin/lb bodyweight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day.

Oral

Pulmotil™ and Monovet®

Cattle fed in confinement for slaughter

Not to exceed 800 g/ton Optaflexx™. Feed a minimum of 1.0 lb/hd/day Ractopamine Type C Top Dress TD + MT continuously to cattle fed in confinement for slaughter, to provide 70 to 400 mg/head/day ractopamine for the last 28 to 42 days on feed. Feed on top of a ration containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin phosphate, to provide 0.14 to 0.42 mg monensin/lb body weight/day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day and 60 to 90 mg/hd/day tylosin.

Oral

Optaflexx™and Monovet® and Tylovet®

Cattle fed in confinement for slaughter

568 to 757 g/ton of Pulmotil™ and 5 to 40 g/ton of Monovet®. To be fed continuously as the sole ration for a single, 14 day period at 568 grams to 757 grams tilmicosin per ton on a 100% dry matter basis (511.2 to 681.3 g per ton on a 90% dry matter basis) to provide 12.5 mg tilmicosin/kg of body weight/day and 5 grams to 40 grams monensin per ton on a 90% dry matter basis (5.6 to 44.4 grams per ton on a 100% dry matter basis) to provide 50 to 480 mg monensin/head/day.

Oral

Pulmotil™ and Monovet®

Cattle fed in confinement for slaughter

Not to exceed 800 g/ton of Actogain™. Feed a minimum of 1.0 lb/head/day Ractopamine Type C Top Dress TD + M continuously to cattle fed in confinement for slaughter to provide 70 to 400 mg/head/day ractopamine for the last 28 to 42 days on feed. Feed on top of a ration containing 10 to 40 g/ton monensin, to provide 0.14 to 0.42 mg monensin/lb body weight/day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day.

Oral

Actogain™ and Monovet®

Cattle fed in confinement for slaughter

8.2 to 24.6 g/ton of Optaflexx™, 10 to 40 g/ton of Monovet®, and 8 to 10 g/ton of Tylovet®. Feed continuously as sole ration to provide 70 to 430 mg/hd/day ractopamine and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day and 60 to 90 mg/hd/day tylosin for the last 28 to 42 days on feed.

Oral

Optaflexx™and Monovet® and Tylovet®

Cattle fed in confinement for slaughter

9.8 to 24.6 g/ton Optaflexx™, 10 to 40 g/ton Monovet®, and 8 to 10 g/ton Tylovet®. Feed continuously as sole ration to provide 90 to 430 mg/hd/day ractopamine and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day and 60 to 90 mg/hd/day tylosin for the last 28 to 42 days on feed.

Oral

Optaflexx™and Monovet® and Tylovet®

Cattle fed in confinement for slaughter

8.2 to 24.6 g/ton of Actogain™ and 10 to 40 g/ton of Monovet®. Feed continuously as sole ration to provide 70 to 430 mg/hd/day ractopamine as ractopamine HCl, and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day monensin for the last 28 to 42 days on feed.

Oral

Actogain™ and Monovet®

Cattle fed in confinement for slaughter

5 to 40 g/ton of Monovet® and 8 to 10 g/ton of Tylovet®. Feed continuously as sole ration to provide 50 to 480 mg/hd/day monensin and 60 to 90 mg/hd/day tylosin. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 g/ton (360 mg monensin per head per day).

Oral

Monovet® and Tylovet®

Cattle fed in confinement for slaughter

10 to 40 g/ton of Monovet® and 8 to 10 g/ton of Tylovet®. Feed continuously as sole ration to provide 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day and 60 to 90 mg/hd/day tylosin.

Oral

Monovet® and Tylovet®

Cattle fed in confinement for slaughter

10 to 40 g/ton to provide 0.14 to 0.42 mg/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day, of monensin (as Monovet®). Feed continuously as sole ration for the last 28 to 42 days on feed.

Oral

Optigrid® and Monovet® and Tylovet®

Cattle fed in confinement for slaughter

Not to exceed 800 g/ton feeding a minimum of 1.0 lb/head/day to provide 70 to 400 mg/head/day of ractopamine hydrochloride (as Optigrid®). Feed continuously as sole ration for the last 28 to 42 days on feed.

Oral

Optigrid® and Monovet®

Cattle fed in confinement for slaughter

10 to 40 g/ton of Monovet®. Feed at a rate of 0.14 to 0.42 milligram per pound of body weight per day, depending upon the severity of challenge, up to maximum of 480 milligrams per head per day.

Oral

Actogain™ and Monovet®

Cattle fed in confinement for slaughter

8.2 to 24.6 g/ton to provide 70 to 430 mg/head/day of ractopamine hydrochloride (as Optigrid®). Feed continuously as sole ration for the last 28 to 42 days on feed.

Oral

Optigrid® and Monovet® and Tylovet®

Cattle fed in confinement for slaughter

Ractopamine hydrochloride top dress (not to exceed 800 g/ton) to be fed with a ration containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin phosphate.

Oral

Feed a minimum of 1.0 lb/hd/day continuously to cattle fed in confinement for slaughter, to provide 70 to 400 mg/head/day ractopamine for the last 28 to 42 days on feed. Feed on top of a ration containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin phosphate, to provide 0.14 to 0.42 mg monensin/lb body weight/day (depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day), and 60 to 90 mg/hd/day tylosin.

Optaflexx™ and Rumensin™ and Tylan™

Cattle fed in confinement for slaughter

8 to 10 g/ton to provide 60 to 90 mg/head/day of tylosin phosphate (as Tylovet®). Feed continuously as sole ration for the last 28 to 42 days on feed.

Oral

Optigrid® and Monovet® and Tylovet®

Cattle fed in confinement for slaughter

Ractopamine hydrochloride (8.2 to 24.6 g/ton) in combination with monensin (10 to 40 g/ton), and tylosin phosphate (8 to 10 g/ton).

Oral

Feed continuously as sole ration to provide 70 to 430 mg ractopamine per hd/day and 0.14 to 0.42 mg monensin per lb body weight/day (depending on severity of coccidiosis challenge, up to 480 mg/hd/day), and 60 to 90 mg tylosin per hd/day for the last 28 to 42 days on feed.

Optaflexx™ and Rumensin™ and Tylan™

Cattle fed in confinement for slaughter

Monensin, 5 to 40 grams per ton of feed, plus tylosin 8 to 10 grams per ton of feed.

Oral

Feed only to cattle being fed in confinement for slaughter. Feed continuously as sole ration to provide 50 to 480 monensin mg/hd/day and 60 to 90 tylosin mg/hd/day. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 g/ton (360 mg monensin per head per day).

Rumensin™ and Tylan™

Cattle Fed in Confinement for Slaughter

Tilmicosin phosphate - 568 to 757 g/ton Monensin – 10 to 40 g/ton 100% dry matter basis 90% dry matter basis

Oral

The safety of tilmicosin has not been established in cattle intended for breeding purposes. Tilmicosin is not approved for use in female dairy cattle 20 months of age or older. Use in these cattle may cause drug residues in milk. Tilmicosin is not approved for use in calves intended to be processed for veal. For cattle fed in confinement for slaughter, feed continuously for 14 days to provide 12.5 mg tilmicosin/kg/head/day. Feed at a rate of 0.14 to 0.42 milligram monensin per pound of body weight per day, depending upon the severity of challenge, up to maximum of 480 milligrams per head per day.

Pulmotil® 90 and Rumensin® 90

Cattle Fed in Confinement for Slaughter

Ractopamine hydrochloride top dress (not to exceed 800g/ton) plus monensin USP (10 to 40 g/ton).

Oral

Feed continuously as sole ration for the last 28 to 42 days on ration. Not for animals intended for breeding. Do not use in calves to be processed for veal.

Optaflexx™ plus Rumensin®

Cattle Fed in Confinement for Slaughter

Ractopamine hydrochloride (8.2 to 24.6 g/ton) in combination with monensin USP (10 to 40 g/ton).

Oral

Feed continuously as sole ration for the last 28 to 42 days on ration. Not for animals intended for breeding. Do not use in calves to be processed for veal.

Optaflexx™ plus Rumensin®

Growing beef steers and heifers fed in confinement for slaughter

400 to 2000 g/ton of chlortetracycline (as Pennchlor®) and 5 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration for not more than 5 days, then continue feeding monensin Type C medicated feed alone. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 grams per ton (360 mg monensin per head per day).

Oral

Pennchlor® and Monovet®

Growing beef steers and heifers fed in confinement for slaughter

Feed as the sole ration to provide 22.7 mg of decoquinate per 100 lb. of body weight per day, 50 to 360 mg of monensin per head per day, and 60 to 90 mg tylosin (as tylosin phosphate) per head per day. Feed for at least 28 days during periods of coccidiosis exposure or when experience indicates that coccidiosis is likely to be a hazard.

Oral

Deccox® and Rumensin™ and Tylovet®

Growing beef steers and heifers fed in confinement for slaughter

1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of Experior™ and 10 to 40 g/ton to provide 0.14 to 0.42 mg/lb body weight per day, depending upon severity of coccidiosis challenge, up to 480 mg/hd/day, of Rumensin™. Feed continuously as sole ration during the last 14 to 91 days on feed.

Oral

Experior™ and Rumensin™

Growing beef steers and heifers fed in confinement for slaughter

Feed continuously in a complete feed 5 to 40 g/ton monensin on a 90% dry matter basis to provide 50 to 480 mg monensin per head per day. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 g/ton (360 mg monensin per head per day).

Oral

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Rumensin™ 90

Growing beef steers and heifers fed in confinement for slaughter

50 to 117 g/ton of chlortetracycline (as Pennchlor®) and 7.14 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 grams per ton (360 mg monensin per head per day).

Oral

Pennchlor® and Monovet®

Growing beef steers and heifers fed in confinement for slaughter

400 to 2000 g/ton of chlortetracycline (as Pennchlor®) and 10 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration for not more than 5 days, then continue to feed monensin Type C medicated feed alone.

Oral

Pennchlor® and Monovet®

Growing beef steers and heifers fed in confinement for slaughter

1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of Experior™ and 5 to 40 g/ton to provide 50 to 480 mg/hd/day of Rumensin™. Feed continuously as sole ration during the last 14 to 91 days on feed.

Oral

Experior™ and Rumensin™

Growing beef steers and heifers fed in confinement for slaughter

Feed continuously (10 to 40 g/ton) to provide 0.14 to 0.42 mg per pound of body weight per day, depending upon severity of challenge, up to a maximum of 480 mg of monensin per head per day.

Oral

Monovet® 90

Growing beef steers and heifers fed in confinement for slaughter

Feed complete feed (5 to 40 g/ton) continuously to growing finishing beef cattle to provide not less than 50 nor more than 480 mg monensin per head per day.

Oral

Monovet® 90

Growing beef steers and heifers fed in confinement for slaughter

50 to 117 g/ton of chlortetracycline (as Pennchlor®) and 10 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration.

Oral

Pennchlor® and Monovet®

Growing beef steers and heifers fed in confinement for slaughter

Decoquinate:12.9 to 90.8 g/ton and Monensin: 5 to 30 g/ton

Oral

Feed as sole ration to provide 22.7 milligrams of decoquinate per 100 lbs of body weight per day and 50 to 360 milligrams of monensin per head per day. Feed for at least 28 days during periods of coccidiosis exposure or when experience indicates that coccidiosis is likely to be a hazard. Do not feed to cows producing milk for human consumption. A withdrawal period has not been established for this product in pre-ruminant calves. Do not use in calves to be processed for veal. Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feeds are safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusal and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Deccox® and Rumensin™

Heifers Fed in Confinement for Slaughter

9.8 to 24.6 grams per ton ractopamine combined with monensin 10 to 40 grams per ton, and melengestrol acetate to provide 0.25 to 0.5 milligrams per head per day.

Oral

Feed continuously as sole ration during the last 28 to 42 days on feed. Not for animals intended for breeding.

Optaflexx™ / Rumensin® / MGA®

Beef Cows

Feed continuously at 50 to 200 mg per head per day. Blend into a minimum of 1 pound of Type C medicated feed and either hand feed or mix into the total ration. Feed (other than the Type C medicated feed containing Rumensin) can be restricted to 95% (of normal requirements) when 50 mg of monensin activity is fed, and to 90% at 200 mg. Cows on pasture or in dry lot must receive a minimum of 1 pound of Type C medicated feed per head per day. Additionally, a minimum of 16 pounds (air-dry basis) of roughage such as silage, haylage, ammoniated straw, hay or equivalent feedstuffs should be fed in order to meet NRC recommendations for beef cows to gain 0.25 to 0.75 pounds per head per day. Standing, dried winter range forage may not be of adequate quality to result in improved e¬fficiency when supplemented with Rumensin. During the first 5 days, pastured cattle should receive no more than 100 mg per day contained in not less than 1 pound of feed. Do not self feed.

Oral

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Rumensin™ 90

Beef Cows

Feed at a rate of 0.14 to 0.42 mg per pound of body weight per day, depending upon severity of challenge, up to a maximum of 200 mg per head per day. During the first 5 days, pastured cattle should receive no more than 100 mg per day contained in not less than 1 pound of feed.

Oral

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Rumensin™ 90

Growing beef steers and heifers on pasture (stocker, feeder, and slaughter) or in a dry lot and Replacement beef and dairy heifers

Feed at the rate of not less than 50 nor more than 200 mg per head per day in not less than one pound of Type C Medicated Feed; or after the 5th day, feed at the rate of 400 mg per head per day every other day in not less than 2 pounds of Type C Medicated Feed. The monensin concentration in the Type C Medicated Feed must be between 15 and 400 grams per ton. During the first 5 days, cattle should receive no more than 100 mg per day contained in not less than 1 pound of feed. Do not self feed.

Oral

Free-Choice (Self-Fed) Medicated Feeds: All Free-choice medicated feeds must provide not less than 50 nor more than 200 mg monensin per head per day.

Monovet® 90

Growing beef steers and heifers on pasture (stocker, feeder, and slaughter) or in a dry lot and Replacement beef and dairy heifers

Feed this supplemental Type C medicated feed containing 15 to 400 g monensin per ton. During the first 5 days, cattle should receive 50 to 100 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed. After 5 days, feed at a rate of 50 to 200 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed OR at a rate of 400 mg monensin per head per day every other day in a minimum of 2 pounds of Type C medicated feed.

Oral

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Rumensin™ 90

Growing beef steers and heifers on pasture (stocker, feeder, and slaughter) or in a dry lot and Replacement beef and dairy heifers

Feed this supplemental Type C medicated feed containing 15 to 400 g monensin per ton to provide 0.14 to 0.42 mg monensin per pound of body weight per day, depending upon severity of challenge. During the first 5 days, cattle should receive a maximum of 100 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed. After 5 days, feed up to a maximum of 200 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed.

Oral

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Type C free-choice medicated feeds All Type C free-choice medicated feeds containing Rumensin must be manufactured according to an FDA-approved formula/specification. When using a formula/specification published in the Code of Federal Regulations (CFR), a Medicated Feed Mill license is not required. Use of Rumensin in a proprietary formula/specification not published in the CFR requires prior FDA approval and a Medicated Feed Mill license.

Rumensin™ 90

Growing beef steers and heifers on pasture (stocker, feeder, and slaughter) or in a dry lot and Replacement beef and dairy heifers

Feed at a rate to provide 0.14 to 0.42 mg per pound body weight per day, depending upon severity of challenge, up to a maximum of 200 mg per head per day. The monensin concentration in Type C Medicated Feed must be between 15 and 400 grams per ton. During the first 5 days, cattle should receive no more than 100 mg per day contained in not less than 1 pound of feed.

Oral

Free-Choice (Self-Fed) Medicated Feeds: All Free-choice medicated feeds must provide not less than 50 nor more than 200 mg monensin per head per day.

Monovet® 90

Calves (excluding veal calves)

Feed at a rate of 0.14 to 1.00 mg per pound of body weight per day, depending upon severity of challenge, up to a maximum of 200 mg of monensin per head per day. The monensin concentration in Type C Medicated Feed must be between 10 and 200 g/ton.

Oral

Monovet® 90

Calves (excluding veal calves)

10 to 200 grams per ton of feed to provide 0.14 to 1.00 mg per pound of body weight per day, depending upon severity of challenge, up to a maximum of 200 mg of monensin per head per day.

Oral

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Rumensin™ 90

Dairy Cows

Total Mixed Rations (“complete feed”): Feed continuously to dry and lactating dairy cows a total mixed ration ("complete feed") containing 11 to 22 g/ton monensin on a 100% dry matter basis. Component Feeding Systems (including top dress): Feed continuously to dry and lactating dairy cows a Type C Medicated Feed containing 11 to 400 g/ton monensin. The Type C Medicated Feed must be fed in a minimum of 1 pound of feed per cow per day to provide 185 to 660 mg/head/day monensin to lactating cows or 115 to 410 mg/head/day monensin to dry cows.

Oral

Monovet® 90

Dairy Cows

Total Mixed Ration (complete feed): Feed continuously 11 to 22 g/ton monensin on a 100% dry matter basis. Component Feeding Systems (including top dress): Feed continuously 11 to 400 g/ton monensin in a minimum of 1 pound Type C medicated feed per cow per day to provide 185 to 660 mg/head/day monensin to lactating cows or 115 to 410 mg/head/day monensin to dry cows.

Oral

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. You may notice reduced voluntary feed intake in dairy cows fed monensin. This reduction increases with higher doses of monensin fed. Rule out monensin as the cause of reduced feed intake before attributing to other causes such as illness, feed management, or the environment. You may notice reduced milk fat percentage in dairy cows fed monensin. This reduction increases with higher doses of monensin fed. You may notice increased incidence and treatment of cystic ovaries and metritis, reduced conception rates, increased services per animal, and extended days open and corresponding calving intervals in dairy cows fed monensin. Have a comprehensive and ongoing nutritional, reproductive and herd health program in place when feeding monensin to dairy cows.

Rumensin™ 90

Cattle (heifers fed in confinement for slaughter

Melengestrol acetate (0.25 to 2 g/ton) in combination with monensin (10 to 40 g/ton) and tylosin (8 to 10 g/ton).

Oral

Feed continuously as sole ration to heifers at a rate of 0.5 to 2.0 pounds per head per day to provide 0.25 to 0.5 mg/head/day melengestrol acetate and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day and 60 to 90 mg/head/day tylosin. The melengestrol acetate portion of this Type C medicatedfeed must be mixed into the complete feed containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin at feeding into the amount of complete feed consumed by an animal per day.Melengestrol acetate is for use only in heifers being fed in confinement for slaughter. Not effective in steers or spayed heifers. Heifers fed in confinement for slaughter: Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at the time of loading.Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.

MGA® and Rumensin™ and Tylan™

Growing beef steers and heifers on pasture (stocker, feeder, and slaughter)

40 to 200 milligrams of monensin (0.25 to 1.13 pounds or 4 to 18 ounces of block) per head per day.

Oral

PASTURE GAINER BLOCK 20 R350 is a free-choice protein block containing 175 mg monensin per pound. Feed one block for every four (4) cattle. Place near watering or loafing areas in a well-drained area. Cattle should consume from 4.0 to 18.0 ounces (0.25 to 1.13 lb) per head per day to provide 40 to 200 mg monensin per head per day. Consumption of this block may vary with temperature and/or quality of forage. If consumption of the block is below 4.0 ounces per head per day, increase number of feeding locations or relocate the blocks to a more frequented area. Blocks should be replenished every 7 to 14 days. Do not allow cattle access to salt or minerals while being fed this block. Ingestion by cattle of monensin at levels of 600 mg per head per day and higher has been fatal. Do not allow horses or other equines access to feed containing monensin. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions; reduced average daily gains may result. Do not feed to sheep due to high levels of supplemental copper.

Pasture Gainer Block 20 R350

Cattle (pasture cattle: slaughter, stocker, feeder, and dairy and beef replacement heifers)

80 to 200 milligrams of monensin (0.2 to 0.5 pound of block) per head per day.

Oral

Block to be fed free choice. Provide at least 1 block per 5 head of cattle. Feed blocks continuously. Do not feed salt or minerals containing salt. Do not allow horses or other equines access to formulations containing monensin (ingestion of monensin by equines has been fatal). The effectiveness of this block in cull cows and bulls has not been established.

Sweetlix Rumensin® Pressed Block

Cattle (growing beef steers and heifers on pasture (stocker, feeder, and slaughter) and replacement beef heifers on pasture)

MoorMan's Mintrate Red Block RU is for growing beef steers and heifers on pasture (stocker, feeder, and slaughter) and replacement beef heifers on pasture when maintained on poor quality pasture or roughage or where pasture is in short supply. If the pasture or roughage is of good quality, Mintrate Blonde Block RU is recommended. Before feeding, be sure cattle are accustomed to protein blocks by feeding unmedicated Mintrate Blocks for 6 to 35 days or until cattle have demonstrated proper consumption. As soon as cattle have demonstrated proper consumption, remove the non-medicated blocks and replace with the recommended amount of Mintrate Red Block RU. Feed this block free-choice. Do not allow animals access to other protein blocks, salt or mineral while being fed this product. Recommended consumption of block is 0.34 to 1.33 lb per head per day to provide 50 to 200 mg monensin per head per day. A 10-day supply of blocks may be put out at one time. Place blocks near water or loafing areas. Not less than one block for each 10 to 12 animals is recommended. Additional blocks should be put out when the current blocks are 75% consumed.

Oral

MoorMan's® Mintrate® Red Block RU

Growing beef heifers fed in confinement for slaughter

0.25 to 2 g/ton of melengestrol acetate (as MGA® 200 or MGA® 500) to provide 0.25 to 0.5 mg melengestrol acetate per head per day, 1.25 to 4.54 g/ton of lubabegron (as lubabegron fumarate) (as Experior™) to provide 13 to 90 mg lubabegron per head per day, 10 to 40 g/ton of monensin (as Rumensin™) to provide 0.14 to 0.42 mg monensin per pound of body weight per day, depending upon severity of challenge, up to a maximum of 480 mg monensin per head per day, and 8 to 10 g/ton of tylosin (as tylosin phosphate) (as Tylan™) to provide 60 to 90 mg tylosin per head per day. The melengestrol acetate Type C top-dress medicated feed (0.5 to 2 lb(s) per head per day) must be top dressed onto or mixed at feeding with a Type C medicated feed containing lubabegron and monensin and tylosin. Feed as the sole ration during the last 14 to 91 days on feed.

Oral

MGA® and Experior™ and Rumensin™ and Tylan™

Growing beef heifers fed in confinement for slaughter

0.25 to 2 g/ton of melengestrol acetate (as MGA® 200 or MGA® 500) to provide 0.25 to 0.5 mg melengestrol acetate per head per day; 1.25 to 4.54 g/ton of lubabegron (as Experior™) to provide 13 to 90 mg lubabegron per head per day; and 10 to 40 g/ton of monensin (as Monovet®) to provide 0.14 to 0.42 mg monensin per pound of body weight per day, depending upon severity of challenge, up to a maximum of 480 mg monensin per head per day. The melengestrol acetate Type C top-dress medicated feed (0.5 to 2 lb per head per day) must be top dressed onto or mixed at feeding with a Type C medicated feed containing lubabegron and monensin. Feed as the sole ration during the last 14 to 91 days on feed.

Oral

MGA® and Experior™ and Monovet®

Growing beef heifers fed in confinement for slaughter

0.25 to 2 g/ton of melengestrol acetate (as CycleGuard®) to provide 0.25 to 0.5 mg melengestrol acetate per head per day and 10 to 40 g/ton of monensin (as Monovet®) to provide 0.14 to 0.42 mg monensin per pound of body weight per day, depending upon severity of challenge, up to a maximum of 480 mg monensin per head per day. The melengestrol acetate Type C top-dress medicated feed (0.5 to 2 lb(s) per head per day) must be top dressed onto or mixed at feeding with a Type C medicated feed containing monensin.

Oral

MGA® and Monovet®

Cattle (Heifer)

Melengestrol acetate (0.125 to 1. 0 mg/lb is top dressed or mixed with a complete ration containing monensin (10 to 40 g/ton), tylosin (8 to 10 g/ton), and zilpaterol (6.8 g/ton).

Oral

Feed continuously as the sole ration for the final 20 to 40 days. Do not use in calves to be processed for veal. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feeds is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Zilpaterol hydrochloride is not for use in animals intended for breeding. Do not allow horses or other equines access to feed containing zilpaterol. Do not use in veal calves. Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90% dry matter basis), zilpaterol should not be fed in complete feed. Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days or more should be avoided to prevent the possibility that the heifers may come into estrus (heat) at loading time. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian. Special considerations: 1) For liquid melengestrol acetate Type C feeds stored in recirculation tank systems, labeling indicates: “Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents from the bottom of the tank to the top. Recirculate daily, as directed in this paragraph even when the Type C feed is not used.” For liquid melengestrol Type C feeds stored in mechanical, air or other agitation-type tank systems: “Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily, as directed in this paragraph, even when the Type C feed is not used.” 2) All labeling for Type C feeds containing zilpaterol hydrochloride provides the warning: The active ingredient in Zilmax® is zilpaterol hydrochloride, a beta2-adrenergic agonist. Not for use in humans. An anti-dust process has been applied to the drug product, Zilmax®, in order to greatly reduce inhalation risk. Extended handling tasks with the potential for dust generation require respiratory protection. Wear appropriate skin protection (e.g., impervious gloves, apron, overalls), if there is a potential for extended skin contact. Wear protective eyewear, if there is a potential for eye contact. If accidental eye contact occurs, immediately rinse with water and consult a physician.

Heifermax® 500/Zilmax®/Rumensin®/Tylan®

Cattle, Beef, Heifers fed in confinement for slaughter

Melengestrol acetate is added to the diet of heifers at 0.5 to 2.0 pounds per head per day of medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound to provide 0.25 to 0.5 mg melengestrol acetate per head per day. Monensin is added to feedlot cattle diets at concentrations of 10 to 40 g of monensin per ton of complete feed at a rate of 0.14 mg to 0.42 mg monensin per pound of body weight depending on the severity of coccidiosis challenge up to 480 mg per head per day. Tylosin is added to the cattle diets at concentrations of 8 to 10 g of tylosin phosphate per ton of complete feed to provide 60 to 90 mg tylosin per head per day.

Oral

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Feed only to cattle being fed in confinement for slaughter. Feed continuously as sole ration. A withdrawal time has not been established in pre-ruminating calves. Do not use in calves to be processed for veal.

MGA®, Rumensin™ and Tylovet® 100

Cattle, Beef, Heifers fed in confinement for slaughter

Feed continuously as sole ration containing 9.8 to 24.6 g/ton ractopamine to provide 90 to 430 mg/hd/day ractopamine; 10 to 40 g/ton monensin to provide 0.14 to 0.42 mg monensin/lb of body weight per day, depending on severity of coccidiosis challenge, up to 480 mg/head/day; 8 to 10 g/ton tylosin to provide 60 to 90 mg/head/day tylosin for the last 28 to 42 days on feed. Mix or top dress with medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound fed at the rate of 0.5 to 2.0 lb/head/day to provide 0.25 to 0.5 mg melengestrol acetate per head per day for the last 28 to 42 days on feed.

Oral

Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at time of loading. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian. Ractopamine HCl is not for animals intended for breeding. Special considerations: Mixing directions for liquid melengestrol acetate Type C feeds stored in recirculation tank systems, labeling indicates: “Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents from the bottom of the tank to the top. Recirculate daily, as directed in this paragraph even when the Type C feed is not used.” For liquid melengestrol Type C feeds stored in mechanical, air or other agitation-type tank systems: “Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily, as directed in this paragraph, even when the Type C feed is not used.”

Optaflexx™ 45/Rumensin®/Tylovet® 100/MGA®

Cattle, Beef, Heifers fed in confinement for slaughter

Melengestrol acetate (0.25 to 2 g/ton) in combination with monensin (10 to 40 g/ton) and tylosin (8 to 10 g/ton).

Oral

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian. Feed continuously as sole ration to heifers at a rate of 0.5 to 2.0 pounds per head per day to provide 0.25 to 0.5 mg/head/day melengestrol acetate and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day and 60 to 90 mg/head/day tylosin. The melengestrol acetate portion of this Type C medicated feed must be mixed into the complete feed containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin at feeding into the amount of complete feed consumed by an animal per day. Melengestrol acetate is for use only in heifers being fed in confinement for slaughter. Not effective in steers or spayed heifers. Heifers fed in confinement for slaughter: Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at the time of loading. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.

MGA®, Rumensin™ and Tylovet® 100

Ractopamine hydrochloride top dress (not to exceed 800 g/ton) to be fed with a ration containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin phosphate.

Oral

Feed a minimum of 1.0 lb/hd/day Ractopamine Type C Top Dress TD + MT continuously to cattle fed in confinement for slaughter, to provide 70 to 400 mg/head/day ractopamine for the last 28 to 42 days on feed. Feed on top of a ration containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin phosphate, to provide 0.14 to 0.42 mg monensin/lb body weight/day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day and 60 to 90 mg/hd/day tylosin. Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Ractopamine HCl is not for animals intended for breeding.

Actogain® and Rumensin™ and Tylan™

Ractopamine hydrochloride (9.8 to 24.6 g/ton) in combination with monensin sodium (10 to 40 g/ton) and tylosin phosphate (8 to 10 g/ton).

Oral

Feed continuously as sole ration to provide 90 to 430 mg/hd/day ractopamine and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day and 60 to 90 mg/hd/day tylosin for the last 28 to 42 days on feed.

Actogain® and Rumensin™ and Tylan™

Heifers fed in confinement for slaughter

Ractopamine is fed continuously as the sole ration at a concentration of 9.8 to 24.6 g of ractopamine hydrochloride per ton of complete feed to provide 90 to 430 mg/hd/day ractopamine/head/day. Monensin is added to the ration at a concentrations of 10 to 40 g of monensin USP per ton of complete feed at a rate of 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day of monensin for the last 28 to 42 days on feed. Melengestrol acetate supplements (liquid and dry): Must be top dressed or mixed with a complete ration containing ractopamine (9.8 to 24.6 g/ton) and monensin (10 to 40 g/ton). Feed at the rate of 0.5 to 2.0 pounds per head per day to provide 0.25 to 0.5 mg melengestrol acetate per head per day. Feed melengestrol acetate in this combination for the final 28 to 42 days on feed.

Oral

Feed continuously as sole ration during the last 28 to 42 days on feed. Not for animals intended for breeding. Do not use in calves to be processed for veal.

Actogain® and Rumensin™ and MGA®

Heifers fed in confinement for slaughter

0.25 to 2 g/ton (0.0000276 to 0.00022%) of MGA®, 10 to 40 g/ton of Monovet®, and 8 to 10 g/ton of Tylovet®. Feed continuously as sole ration to heifers at a rate of 0.5 to 2.0 pounds per head per day to provide 0.25 to 0.5 mg/head/day melengestrol acetate and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day and 60 to 90 mg/head/day tylosin. The melengestrol acetate portion of this Type C medicated feed must be mixed into the complete feed containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin at feeding into the amount of complete feed consumed by an animal per day.

Oral

MGA® and Monovet® and Tylovet®

Heifers fed in confinement for slaughter

Feed continuously as sole ration containing 9.8 to 24.6 g/ton ractopamine hydrochloride to provide 90 to 430 mg/head/day ractopamine hydrochloride, 10 to 40 g/ton monensin to provide 0.14 to 0.42 mg monensin/lb of body weight per day (depending on severity of coccidiosis challenge, up to 480 mg/head/day), and 0.125 to 1.0 mg melengestrol acetate per pound to provide 0.5 to 2.0 lb/head/day for the last 28 to 42 days on feed. The melengestrol acetate Type C medicated feed (fed at the rate of 0.5 to 2.0 lb/head/day) must be top dressed onto or mixed at feeding with Type C medicated feed containing ractopamine hydrochloride and monensin.

Oral

Optigrid® and Monovet® and CycleGuard®

Heifers fed in confinement for slaughter

Feed continuously as sole ration containing 9.8 to 24.6 g/ton ractopamine hydrochloride to provide 90 to 430 mg/head/day ractopamine hydrochloride; 10 to 40 g/ton monensin to provide 0.14 to 0.42 mg monensin/lb of body weight per day, depending on severity of coccidiosis challenge, up to 480 mg/head/day; 8 to 10 g/ton tylosin to provide 60 to 90 mg/head/day tylosin for the last 28 to 42 days on feed. Mix or top dress with medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound fed at the rate of 0.5 to 2.0 lb/head/day to provide 0.25 to 0.5 mg melengestrol acetate per head per day for the last 28 to 42 days on feed.

Oral

Optigrid® and Monovet® and Tylovet® and CycleGuard®

Heifers fed in confinement for slaughter

0.125 to 1.0 mg/lb of MGA® for increased rate of weight gain, improved feed efficiency and suppression of estrus (heat) in heifers fed in confinement for slaughter. Must be top dressed or mixed with a complete ration containing monensin (10 to 40 g/ton), tylosin (8 to 10 g/ton) and ractopamine (9.8 to 24.6 g/ton). Feed at the rate of 0.5-2.0 pound(s) per head per day (specify one level) to provide 0.25-0.5 mg melengestrol acetate per head per day (specify one level). Feed melengestrol acetate in this combination for the final 28 to 42 days on feed.

Oral

Optaflexx™ and Monovet® and Tylan™ and MGA®

Heifers fed in confinement for slaughter

0.125 to 1.0 mg/lb of MGA®. Must be top dressed or mixed with a complete ration containing monensin (10 to 40 g/ton), tylosin (8 to 10 g/ton) and ractopamine (9.8 to 24.6 g/ton). Feed at the rate of 0.5-2.0 pound(s) per head per day (specify one level) to provide 0.25-0.5 mg melengestrol acetate per head per day (specify one level). Feed melengestrol acetate in this combination for the final 28 to 42 days on feed.

Oral

Optaflexx™ and Monovet® and Tylovet® and MGA®

Heifers fed in confinement for slaughter

9.8 to 24.6 g/ton of Optaflexx™, 10 to 40 g/ton of Monovet®, and 8 to 10 g/ton of Tylovet®. Feed continuously as sole ration to provide 90 to 430 mg/hd/day ractopamine and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day and 60 to 90 mg/hd/day tylosin for the last 28 to 42 days on feed.

Oral

Optaflexx™ and Monovet® and Tylovet® and MGA®

Heifers fed in confinement for slaughter

9.8 to 24.6 g/ton of Actogain™ and 10 to 40 g/ton of Monovet®. Feed continuously as sole ration to provide 90 to 430 mg/hd/day ractopamine and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day monensin for the last 28 to 42 days on feed.

Oral

Actogain™ and Monovet® and MGA®

Heifers fed in confinement for slaughter

10 to 40 g/ton to provide 0.14 to 0.42 mg/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day, of monensin (as Monovet®). Feed continuously as sole ration for the final 28 to 42 days on feed.

Oral

Optigrid® and Monovet® and MGA®

Heifers fed in confinement for slaughter

0.125 to 1.0 mg/lb fed at the rate of 0.5 to 2.0 lb/head/day (specify one level) to provide 0.25 to 0.5 mg/head/day (specify one level) of melengestrol acetate (as MGA®). Feed continuously as sole ration for the final 28 to 42 days on feed.

Oral

Optigrid® and Monovet® and MGA®

Heifers fed in confinement for slaughter

9.8 to 24.6 g/ton to provide 90 to 430 mg/head/day of ractopamine hydrochloride (as Optigrid®). Feed continuously as sole ration for the final 28 to 42 days on feed.

Oral

Optigrid® and Monovet® and MGA®

Heifers fed in confinement for slaughter

8 to 10 g/ton to provide 60 to 90 mg/head/day of tylosin phosphate (as Tylovet®). Feed continuously as sole ration for the final 28 to 42 days on feed.

Oral

Optigrid® and Monovet® and Tylovet® and MGA®

Cattle, Beef heifers fed in confinement for slaughter

Ractopamine is fed at concentrations of 9.8 to 24.6 g of ractopamine hydrochloride per ton of complete feed (based on 90% dry matter basis) to provide 90 to 430 mg ractopamine/head/day in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. Monensin is added to feedlot cattle diets at concentrations of 10 to 40 g of monensin USP per ton of complete feed at a rate of 0.14 to 0.42 mg monensin/lb of body weight, depending on severity of coccidiosis challenge, up to 480 mg/head/day. Tylosin is added to the cattle diets at concentrations of 8 to 10 g of tylosin phosphate per ton of complete feed to provide 60 to 90 mg tylosin/head/day. Melengestrol acetate is added to the diet of heifers at 0.5 to 2.0 pounds per head per day of medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound to provide 0.25 to 0.5 mg melengestrol acetate/head/day in heifers being fed for slaughter.

Oral

Feed continuously as sole ration during the last 28 to 42 days on feed. Not for animals intended for breeding. Do not use in calves to be processed for veal.Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Actogain™ 45/Rumensin®/Tylan®/MGA®

Cattle, Beef fed in confinement for slaughter

Ractopamine hydrochloride top dress (not to exceed 800 g/ton) to be fed with a ration containing 10 to 40 g/ton monensin in combination with 8 to 10 g/ton tylosin phosphate.

Oral

Feed continuously as sole ration during the last 28 to 42 days on feed. Do not use in calves to be processed for veal. Ractopamine HCl is not for animals intended for breeding. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Actogain™ 45/Rumensin®/Tylovet® 100

Cattle, Beef fed in confinement for slaughter

Ractopamine hydrochloride (8.2 to 24.6 g/ton) in combination with monensin USP (10 to 40 g/ton) and tylosin phosphate (8 to 10 g/ton).

Oral

Feed continuously as sole ration to provide 70 to 430 mg ractopamine per hd/day and 0.14 to 0.42 mg monensin per lb body weight/day (depending on severity of coccidiosis challenge, up to 480 mg/hd/day), and 60 to 90 mg tylosin per hd/day for the last 28 to 42 days on feed. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Ractopamine HCl is not for animals intended for breeding. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Optaflexx™ 45/Rumensin®/Tylovet® 100

Growing beef steers and heifers on pasture (stocker, feeder, and slaughter) and replacement beef heifers on pasture

50 to 200 milligrams of monensin (2 to 8 ounces of block) per head per day.

Oral

Blocks to be fed free choice. Provide at least one block per five head of cattle. Feed blocks continuously. Discontinue feeding if block consumption falls below 2 oz. or rises above 8 oz daily. Do not feed salt or mineral supplements in addition to the blocks. Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result

CATTLE BLOCK RU-MIN

Cattle (beef fed in confinement for slaughter)

Tilmicosin phosphate – 568 to 757 g/ton and monensin – 10 to 40 g/ton

Oral

The safety of tilmicosin has not been established in cattle intended for breeding purposes. Cattle intended for human consumption must not be slaughtered within 28 days of the last treatment with tilmicosin. Tilmicosin is not approved for use in female dairy cattle 20 months of age or older. Use in these cattle may cause drug residues in milk. Tilmicosin and monensin are not approved for use in calves intended to be processed for veal. A withdrawal period has not been established in pre-ruminating calves.

Tilmovet® 90 and Rumensin® 90

Beef cows

Feed continuously at a rate of 50 to 200 mg per head per day. Blend into a minimum of 1 pound of Type C Medicated Feed and either hand feed or mix into the total ration. Feed (other than the Type C Medicated Feed containing Monovet® 90) can be restricted to 95% (of normal requirements) when 50 mg of monensin activity is fed, and to 90% at 200 mg. Cows on pasture or in dry lot must receive a minimum of 1 pound of Type C Medicated Feed per head per day. Additionally, a minimum of 16 pounds (air-dry basis) of roughage such as silage, haylage, ammoniated straw, hay or equivalent feedstuffs should be fed in order to meet NRC recommendations for mature reproducing beef cows to gain 0.25 to 0.75 pounds per head per day. Standing, dried winter range forage may not be of adequate quality to result in improved efficiency when supplemented with Monovet® 90. During the first 5 days, pastured cattle should receive no more than 100 mg per day contained in not less than 1 pound of feed. Do not self feed.

Oral

Monovet® 90

Beef cows

Feed at a rate of 0.14 to 0.42 mg per pound of body weight per day, depending upon severity of challenge, up to a maximum of 200 mg per head per day. During the first 5 days, pastured cattle should receive no more than 100 mg per day contained in not less than 1 pound of feed.

Oral

Monovet® 90

Beef steers and heifers fed in confinement for slaughter

1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of lubabegron (as Experior™), 10 to 40 g/ton to provide 0.14 to 0.42 mg/lb body weight per day, depending upon severity of coccidiosis challenge, up to 480 mg/hd/day, ofmonensin (as Monovet®), and 8 to 10 g/ton to provide 60 to 90 mg/hd/day of tylosin (as Tylovet®). Feed continuously as the sole ration during the last 14 to 91 days on feed.

Oral

Experior™ and Monovet® and Tylovet®

Beef steers and heifers fed in confinement for slaughter

1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of Experior™; 10 to 40 g/ton to provide 0.14 to 0.42 mg/lb body weight per day, depending upon severity of coccidiosis challenge, up to 480 mg/hd/day, of Rumensin™; and 8 to 10 g/ton to provide 60 to 90 mg/hd/day of Tylan™ Feed continuously as sole ration during the last 14 to 91 days on feed.

Oral

Experior™ and Rumensin™ and Tylan™

Beef steers and heifers fed in confinement for slaughter

1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of lubabegron (as Experior™) and 10 to 40 g/ton to provide 0.14 to 0.42 mg/lb body weight per day, depending upon severity of coccidiosis challenge, up to 480 mg/hd/day, of monensin (as Monovet®). Feed continuously as the sole ration during the last 14 to 91 days on feed.

Oral

Experior™ and Monovet®

Beef steers and heifers fed in confinement for slaughter

1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of lubabegron (as Experior™), 5 to 40 g/ton to provide 50 to 480 mg/hd/day of monensin (as Monovet®), and 8 to 10 g/ton to provide 60 to 90 mg/hd/day of tylosin (as Tylovet®). Feed continuously as the sole ration during the last 14 to 91 days on feed.

Oral

Experior™ and Monovet® and Tylovet®

Beef steers and heifers fed in confinement for slaughter

1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of Experior™; 5 to 40 g/ton to provide 50 to 480 mg/hd/day of Rumensin™; and 8 to 10 g/ton to provide 60 to 90 mg/hd/day of Tylan™. Feed continuously as sole ration during the last 14 to 91 days on feed.

Oral

Experior™ and Rumensin™ and Tylan™

Beef steers and heifers fed in confinement for slaughter

1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of lubabegron (as Experior™) and 5 to 40 g/ton to provide 50 to 480 mg/hd/day of monensin (as Monovet®). Feed continuously as the sole ration during the last 14 to 91 days on feed.

Oral

Experior™ and Monovet®

Growing beef heifers and heifers fed in confinement for slaughter

12.9 to 90.8 g/ton of decoquinate and 5 to 30 g/ton of monensin. Feed as the sole ration to provide 22.7 of mg decoquinate per 100 lb of body weight per day and 50 to 360 mg of monensin per head per day. Feed for at least 28 days during periods of coccidiosis exposure or when experience indicates that coccidiosis is likely to be a hazard.

Oral

Deccox® and Monovet®

Beef calves 2 months of age and older, and growing beef steers and heifers fed in confinement for slaughter

10 mg/lb body weight/day of chlortetracycline (as Pennchlor®) and 50 to 480 mg/head/day of monensin (as Rumensin™). Feed as the sole ration for not more than 5 days, then continue feeding monensin Type C medicated feed alone. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 grams/ton (360 mg monensin per head per day).

Oral

Pennchlor® and Rumensin™

Beef calves 2 months of age and older, and growing beef steers and heifers fed in confinement for slaughter

10 mg/lb body weight/day of chlortetracycline (as Pennchlor®) and 0.14 to 0.42 mg/lb body weight/day of monensin (as Rumensin™) to provide, depending upon severity of the coccidiosis challenge, up to 480 mg/head/day of monensin. Feed as the sole ration for not more than 5 days, then continue to feed monensin Type C medicated feed alone.

Oral

Pennchlor® and Rumensin™

Beef calves 2 months of age and older, and growing beef steers and heifers fed in confinement for slaughter

10 mg/lb body weight/day of chlortetracycline (as Pennchlor®) and 0.14 to 1.00 mg/lb body weight/day of monensin (as Rumensin™) to provide, depending upon severity of coccidiosis challenge, up to 200 mg/head/day of monensin. Feed as the sole ration for not more than 5 days, then continue to feed monensin Type C medicated feed alone.

Oral

Pennchlor® and Rumensin™

Beef calves 2 months of age and older, and growing beef steers and heifers fed in confinement for slaughter

0.5 mg/lb body weight/day of chlortetracycline (as Pennchlor®) and 50 to 480 mg/head/day of monensin (as Rumensin™). Feed as the sole ration. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 grams/ton (360 mg monensin per head per day).

Oral

Pennchlor® and Rumensin™

Beef calves 2 months of age and older, and growing beef steers and heifers fed in confinement for slaughter

0.5 mg/lb body weight/day of chlortetracycline (as Pennchlor®) and 0.14 to 0.42 mg/lb body weight/day of monensin (as Rumensin™) to provide, depending upon severity of coccidiosis challenge, up to 480 mg/head/day of monensin. Feed as the sole ration.

Oral

Pennchlor® and Rumensin™

Replacement beef and dairy heifers

400 to 2,000 g/ton of chlortetracycline (as Pennchlor®) and 15 to 84 g/ton of monensin (as Monovet®). For replacement beef and dairy heifers not currently being fed monensin: feed as the sole ration for not more than 5 days to provide 10 mg chlortetracycline per pound of body weight per day and 0.14 to 0.42 mg monensin per pound of body weight per day, depending upon severity of challenge, to provide 50 to 100 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed. After 5 days, continue to feed monensin Type C medicated feed alone to provide 50 to 200 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed. For replacement beef and dairy heifers currently being fed monensin: feed as the sole ration for not more than 5 days to provide 10 mg chlortetracycline per pound of body weight per day and 0.14 to 0.42 mg monensin per pound of body weight per day, depending upon severity of challenge, to provide 50 to 200 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed. After 5 days, continue to feed monensin Type C medicated feed alone.

Oral

Pennchlor® and Monovet®

Replacement beef and dairy heifers

400 to 2,000 g/ton of chlortetracycline (as Pennchlor®) and 15 to 400 g/ton of monensin (as Monovet®). For replacement beef and dairy heifers not currently being fed monensin: feed as the sole ration for not more than 5 days to provide 10 mg chlortetracycline per pound of body weight per day and 50 to 100 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed. After 5 days, continue to feed monensin Type C medicated feed alone to provide 50 to 200 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed. For replacement beef and dairy heifers currently being fed monensin: feed as the sole ration for not more than 5 days to provide 10 mg chlortetracycline per pound of body weight per day and 50 to 200 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed. After 5 days, continue to feed monensin Type C medicated feed alone.

Oral

Pennchlor® and Monovet®

Replacement beef and dairy heifers

10 mg/lb body weight/day of chlortetracycline (as Pennchlor®) and 0.14 to 0.42 mg/lb body weight/day of monensin (as Rumensin™), depending upon severity of challenge, to provide 50 to 100 mg/head/day of monensin. Feed in a minimum of 1 pound of Type C medicated feed as the sole ration for not more than 5 days. For replacement beef and dairy heifers not currently being fed monensin, continue to feed monensin Type C medicated feed alone to provide 50 to 200 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed. For replacement beef and dairy heifers currently being fed monensin, continue to feed monensin Type C medicated feed alone.

Oral

Pennchlor® and Rumensin™

Beef calves 2 months of age and older

400 to 2000 g/ton of chlortetracycline (as Pennchlor®) and 10 to 200 g/ton of monensin (as Monovet®). Feed as the sole ration for not more than 5 days, then continue to feed monensin Type C medicated feed alone.

Oral

Pennchlor® and Monovet®

Growing beef steers and heifers fed in confinement for slaughter over 700 lbs

33.33 to 66.67 g/ton of chlortetracycline (as Pennchlor®) and 5 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 grams per ton (360 mg monensin per head per day).

Oral

Pennchlor® and Monovet®

Growing beef steers and heifers fed in confinement for slaughter over 700 lbs

33.33 to 66.67 g/ton of chlortetracycline (as Pennchlor®) and 10 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration.

Oral

Pennchlor® and Monovet®

Growing beef steers and heifers fed in confinement for slaughter over 400 lbs

7 to 17.5 g/ton of chlortetracycline (as Pennchlor®) and 5 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 grams per ton (360 mg monensin per head per day).

Oral

Pennchlor® and Monovet®

Growing beef steers and heifers fed in confinement for slaughter over 400 lbs

7 to 17.5 g/ton of chlortetracycline (as Pennchlor®) and 10 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration.

Oral

Pennchlor® and Monovet®

Growing beef steers and heifers fed in confinement for slaughter under 700 lbs

50 to 117 g/ton of chlortetracycline (as Pennchlor®) and 7.14 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 grams per ton (360 mg monensin per head per day).

Oral

Pennchlor® and Monovet®

Growing beef steers and heifers fed in confinement for slaughter under 700 lbs

50 to 117 g/ton of chlortetracycline (as Pennchlor®) and 10 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration.

Oral

Pennchlor® and Monovet®

Cattle/growing beef steers and heifers fed in confinement for slaughter

8.2 to 24.6 g/ton of ractopamine hydrochloride (as Optaflexx™) to provide 70 to 400 mg/head/day of ractopamine hydrochloride, 10 to 40 g/ton of monensin (as Rumensin™) to provide 0.14 to 0.42 mg/lb body weight per day, depending on the severity of coccidiosis challenge, up to 480 mg/head/day of monensin, and 13.5 to 16 g/ton of virginiamycin (as V-Max®) to provide 85 to 240 mg/head/day of virginiamycin. Feed a minimum of 1.0 lb per head per day of this Type C top-dress medicated feed during the last 28 to 42 days on feed.

Oral

Optaflexx™ and Rumensin™ and V-Max®

Cattle/growing beef steers and heifers fed in confinement for slaughter

8.2 to 24.6 g/ton of ractopamine hydrochloride (as Optaflexx™) to provide 70 to 430 mg/head/day of ractopamine hydrochloride, 10 to 40 g/ton of monensin (as Rumensin™) to provide 0.14 to 0.42 mg/lb body weight per day, depending on the severity of coccidiosis challenge, up to 480 mg/head/day of monensin, and 13.5 to 16 g/ton of virginiamycin (as V-Max®) to provide 85 to 240 mg/head/day of virginiamycin. Feed at every feeding as a sole ration during the last 28 to 42 days on feed.

Oral

Optaflexx™ and Rumensin™ and V-Max®

Cattle/growing beef steers and heifers fed in confinement for slaughter

1.25 to 4.54 g/ton of lubabegron (as lubabegron fumarate) (as Experior™) to provide 13 to 90 mg/head/day of lubabegron, 10 to 40 g/ton of monensin (as Rumensin™) to provide 0.14 to 0.42 mg/lb body weight per day, depending on the severity of coccidiosis challenge, up to 480 mg/head/day of monensin, and 13.5 to 16 g/ton of virginiamycin (as V-Max®) to provide 85 to 240 mg/head/day of virginiamycin. Feed at every feeding as sole ration during the last 14 to 91 days on feed.

Oral

Experior™ and Rumensin™ and V-Max®

Cattle/growing beef steers and heifers fed in confinement for slaughter

1.25 to 4.54 g/ton of lubabegron (as lubabegron fumarate) (as Experior™) to provide 13 to 90 mg/head/day of lubabegron, 5 to 40 g/ton of monensin (as Rumensin™) to provide 50 to 480 mg/head/day of monensin, and 13.5 to 16 g/ton of virginiamycin (as V-Max®) to provide 85 to 240 mg/head/day of virginiamycin. Feed at every feeding as sole ration during the last 14 to 91 days on feed.

Oral

Experior™ and Rumensin™ and V-Max®

Cattle/growing beef steers and heifers fed in confinement for slaughter

10 to 40 g/ton of monensin (as Rumensin™) to provide 0.14 to 0.42 mg/lb body weight per day, depending on the severity of coccidiosis challenge, up to 480 mg/head/day of monensin and 13.5 to 16 g/ton of virginiamycin (as V-Max®) to provide 85 to 240 mg/head/day of virginiamycin. Feed at every feeding.

Oral

Rumensin™ and V-Max®

Cattle/growing beef steers and heifers fed in confinement for slaughter

5 to 40 g/ton of monensin (as Rumensin™) to provide 50 to 480 mg/head/day of monensin and 13.5 to 16 g/ton of virginiamycin (as V-Max®) to provide 85 to 240 mg/head/day of virginiamycin. Feed at every feeding.

Oral

Rumensin™ and V-Max®

Laying Hen Replacement Chickens and Layer Breeder Replacement Chickens

90 to 110 grams monensin, USP, per ton of Type C medicated feed. Feed as the sole ration.

Oral

Do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses and guinea fowl has been fatal. Not for broiler breeder replacement chickens.

Coban™ 90

Broiler Chickens

Monensin, 90 to 110 grams per ton of feed, plus bacitracin zinc, 4 to 50 grams per ton of feed, and roxarsone, 22.7 to 45.4 grams (0.0025 percent to 0.005 percent) per ton of feed.

Oral

Do not feed to laying chickens. Feed continuously as the sole ration. Withdraw 5 days before slaughter. As sole source of organic arsenic. Do not allow horses or other equines access to formulations containing monensin. Ingestion of monensin by equines has been fatal. Do not allow horses or other equines access to formulations containing monensin. Ingestion of monensin by equines has been fatal. Must be thoroughly mixed in feeds before use. Do not feed undiluted.

3-Nitro® / Albac® / Coban®

Broiler Chickens

Bambermycins, 1 gram per ton of feed plus monensin, 90 to 110 grams per ton of feed plus roxarsone, 22.7 to 45.4 grams (.0025 to .005 percent) per ton of feed.

Oral

Do not feed to laying chickens. Feed continuously as sole ration. Use as sole source of organic arsenic. Withdraw 5 days before slaughter.

3-Nitro® / Coban® / Flavomycin®

Broiler Chickens

Monensin, 90 to 110 grams per ton of feed. Bacitracin (as feed grade bacitracin zinc), 4 to 50 grams per ton of feed. Feed as the sole ration.

Oral

CobanTM and Albac®

Broiler Chickens

Monensin 90 to 110 grams per ton of feed, plus lincomycin, 2 grams per ton of feed and roxarsone 15 to 30 grams per ton of feed.

Oral

Do not feed to laying chickens. Feed continuously as the sole ration. Withdraw 5 days before slaughter. Sole source of organic arsenic. Must be thoroughly mixed in feeds before use. Do not feed undiluted. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Consumption by unapproved species may result in toxic reactions.

Coban® / Lincomix® / Roxarsone

Broiler Chickens

Monensin, 90 to 110 grams per ton of feed plus bambermycins, 1 to 2 grams per ton of feed.

Oral

Do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses and guinea fowl has been fatal. In the absence of coccidiosis in broiler chickens the use of monensin with no withdrawal period may limit feed intake resulting in reduced weight gain. Not for broiler breeder replacement chickens.

Flavomycin® and Coban™

Broiler Chickens

90 to 110 grams monensin, USP, per ton of Type C medicated feed. Feed as the sole ration.

Oral

Do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses and guinea fowl has been fatal. In the absence of coccidiosis in broiler chickens the use of monensin with no withdrawal period may limit feed intake resulting in reduced weight gain. Not for broiler breeder replacement chickens.

Coban™ 90

Broiler Chickens

Monensin, 90 to 110 grams, plus tylosin phosphate, 4 to 50 grams per ton.

Oral

Feed continuously as sole ration. In the absence of coccidiosis, the use of monensin with no withdrawal period may limit feed intake resulting in reduced weight gain. Do not feed to laying chickens. Do not allow horses or other equines access to formulations containing monensin. Ingestion of monensin by equines has been fatal. Must be thoroughly mixed in feeds before use. Do not feed undiluted.

Coban® / Tylan®

Broiler Chickens

Virginiamycin: 5 - 15 g/ton Monensin sodium: 90 - 110 g/ton

Oral

Feed continuously as the sole ration for broiler chickens. Do not feed to laying chickens. Do not allow horses or other equines access to formulations containing monensin sodium (ingestion of monensin sodium by equines has been fatal).

Coban® / Stafac®

Chickens (broilers)

500 grams chlortetracycline and 90 to 110 g monensin per ton of Type C medicated feed. Feed for five days as the sole ration. Do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses and guinea fowl has been fatal. In the absences of coccidiosis in broiler chickens, use of monensin with no withdrawal period may limit feed intake, resulting in reduced gains. Not to be fed for more than 5 days. Do not feed to chickens over 16 weeks of age.

Oral

Aureomycin® and Coban™

Chickens (broilers)

Monensin, 90 to 110 grams per ton of feed, plus bacitracin zinc, 4 to 50 grams per ton of feed, and roxarsone, 15 to 45.4 grams (0.0017 percent to 0.005 percent) per ton of feed.

Oral

Do not feed to laying chickens;. Feed continuously as the sole ration. Withdraw 5 days before slaughter. As sole source of organic arsenic. Feed must be used within 4 weeks of manufacture. As monensin sodium. Do not allow horses or other equines access to formulations containing monensin. Ingestion of monensin by equines has been fatal.

3-Nitro®-10 / Baciferm® / Coban® Premix

Chickens (broilers)

Monensin 90 to 110 grams per ton of feed, plus bacitracin methylene disalicylate 10 to 25 grams per ton of feed, and roxarsone, 11.3 to 45.4 grams per ton of feed.

Oral

Do not feed to laying chickens. Feed continuously as sole ration. Withdraw 5 days before slaughter. As sole source of organic arsenic.

Coban® plus 3-NITRO® plus BMD®

Chickens (broilers)

Monensin 90 to 110 grams per ton of feed plus bacitracin 100 to 200 grams per ton of feed and roxarsone 22.7 to 45.4 grams per ton of feed.

Oral

For broiler chickens only. Feed continuously as sole ration. Use as sole source of organic arsenic. Withdraw 5 days before slaughter. Do not feed to laying hens. To control necrotic enteritis, start medication at first clinical signs of disease. The dosage range permitted provides for different levels based on the severity of infection. Use continuously for 5 to 7 days or as long as clinical signs persist, then reduce dosage to prevention level. Animals should have access to drinking water at all times. Drug overdosage or lack of water may result in leg weakness. Do not allow horses or other equines access to formulations containing monensin. Ingestion of monensin by equines has been fatal.

3-Nitro® / BMD® / Coban®

Chickens (broilers)

Monensin, 90 to 110 grams, plus bacitracin zinc, 4 to 50 grams, and roxarsone, 15 to 45.4 grams (0.0017 percent to 0.005 percent).

Oral

Do not feed to laying chickens. Feed continuously as the sole ration. Withdraw 5 days before slaughter. As sole source of organic arsenic.

3-Nitro® / Albac® / Coban®

Chickens (broilers)

Monensin, 90 to 110 grams per ton of feed, plus bacitracin methylene disalicylate, 4 to 50 grams per ton of feed.

Oral

Do not fed to laying chickens. Feed continuously as sole ration. In the absence of coccidiosis, the use of monensin with no withdrawal period may limit feed intake resulting in reduced weight gain. As monensin sodium.

Coban® / BMD®

Chickens (broilers)

Monensin 90 to 110 grams, plus virginiamycin, 5 to 15 grams, and roxarsone, 22.7 grams (0.0025 percent).

Oral

Do not feed to laying chickens. Feed continuously as the sole ration. Withdraw 5 days before slaughter. As sole source of organic arsenic. As monensin sodium; as roxarsone. Do not allow horses or other equines access to formulations containing monensin. Ingestion of monensin by equines has been fatal.

3-Nitro® / Stafac® / Coban®

Chickens (broilers)

Monensin 90 to 110 grams per ton of feed plus roxarsone 45.4 grams (0.005 percent) per ton of feed.

Oral

Do not feed to laying chickens. Feed continuously as the sole ration. As sole source of organic arsenic. As monensin or monensin sodium. Labeling: The labeling of Type A articles containing monensin intended for use in chickens shall bear the following caution statements: Do not feed undiluted. Do not feed to laying chickens. Do not allow horses, other equines, mature turkeys or guinea fowl access to feed containing monensin. Ingestion of monensin by horses and guinea fowl has been fatal. In the absence of coccidiosis in broiler chickens the use of monensin with no withdrawal period may limit feed intake resulting in reduced weight gain.

Coban® plus 3-Nitro®

Chickens (broilers)

Monensin, 90 to 110 grams per ton of feed, plus 500 grams chlortetracycline per ton of feed.

Oral

Pennchlor® and Coban™

Chickens (broilers)

Monensin 90 – 110 grams per ton of feed plus bacitracin zinc 10 – 30 grams per ton of feed.

Oral

Do not feed to laying chickens. Feed continuously as sole ration. In the absence of coccidiosis, the use of monensin with no withdrawal period may limit feed intake resulting in reduced weight gain.

Coban™ plus Baciferm®

Chickens (broilers)

90 or 110 grams monensin and 200 grams oxytetracycline per ton of Type C medicated feed.

Oral

Feed continuously as sole ration. Withdraw 72 hours before slaughter. Do not feed to laying chickens. Do not feed to chickens over 16 weeks of age. Do not use in low-calcium feed containing less than 0.55% dietary calcium. Use in such feeds may result in violative residues. Do not allow horses other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses andguinea fowl has been fatal. In the absence of coccidiosis in broiler chickens, use of monensin with no withdrawal period may limit feed intake, resulting in reduced weight gain. Not for replacement chickens intended to become breeding chickens.

Coban™/TM®

Replacement Chicken

Monensin: 90 to 110 g/ton Bacitracin methylene disalicylate: 100 to 200 g/ton Roxarsone: 22.7 to 45.4 g/ton

Oral

To control a necrotic enteritis outbreak, start medication at first clinical signs of disease. The dosage range permitted provides for different levels based on severity of the infection. Administer continuously for 5 to 7 days or as long as clinical signs persist, then reduce bacitracin methylene disalicylate to prevention level (50 g/ton). For replacement chickens intended for use as cage layers only. Do not feed to laying chickens. Do not feed to chickens over 16 weeks of age. Do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses, mature turkeys, and guinea fowl has been fatal. Use as the sole source of organic arsenic. Poultry should have access to drinking water at all times. Drug overdosage or lack of water may result in leg weakness or paralysis.

3-Nitro® / BMD® / Coban®

Replacement Chicken

Monensin: 90 to 110 g/ton Bacitracin methylene disalicylate: 4 to 50 g/ton

Oral

Feed continuously as sole ration. For replacement chickens intended for use as cage layers only. Do not feed to laying chickens. Do not feed to chickens over 16 weeks of age. Do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses, mature turkeys, and guinea fowl has been fatal.

BMD® / Coban®

Replacement Chickens

Monensin: 90 to 110 g/ton Roxarsone: 22.7 to 45.4 g/ton

Oral

Feed continuously as sole ration. For replacement chickens intended for use as cage layers only. Do not feed to laying chickens. Do not feed to chickens over 16 weeks of age. Do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses, mature turkeys, and guinea fowl has been fatal. Use as the sole source of organic arsenic. Poultry should have access to drinking water at all times. Drug overdosage or lack of water may result in leg weakness or paralysis.

3-Nitro® / Coban®

Broiler and Replacement Chickens

Monensin: 90 to 110 g/ton Bacitracin methylene disalicylate: 50 g/ton

Oral

Feed continuously as sole ration. For replacement chickens intended for use as cage layers only. Do not feed to laying chickens. Do not feed to chickens over 16 weeks of age. Do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses, mature turkeys, and guinea fowl has been fatal.

BMD® / Coban®

Broiler chickens

50 g/ton of bacitracin (as feed grade bacitracin methylenedisalicylate provided by Pennitracin MD®) and 90 to 110 g/ton of monensin (as Coban™). Feed as the sole ration for 28 to 35 days, starting from the time chicks are placed for brooding.

Oral

Pennitracin MD® and Coban™

Broiler chickens

4 to 50 g/ton of bacitracin (as feed grade bacitracin methylenedisalicylate provided by Pennitracin MD®) and 90 to 110 g/ton of monensin (as Coban™). Feed as the sole ration throughout the feeding period.

Oral

Pennitracin MD® and Coban™

Broiler chickens

13.6 to 40.9 g/ton of avilamycin (as Inteprity™) and 90 to 110 g/ton of monensin (as Coxidin®). Feed this complete Type C medicated feed as the sole ration for 21 consecutive days.

Oral

Inteprity™ and Coxidin®

Broiler chickens

1 to 2 g/ton of bambermycins (as Flavomycin®) and 90 to 110 g/ton of monensin (as Coxidin®). Feed this complete Type C medicated feed as the sole ration.

Oral

Flavomycin® and Coxidin®

Broiler chickens

90 to 110 g/ton monensin and 2 g/ton lincomycin (as lincomycin hydrochloride agricultural grade) in Type C medicated feed. Feed as the sole ration.

Oral

Coban™ and LINCOMIX®

Broiler chickens

90 to 110 g/ton of monensin (as Coxidin®) and 5 to 25 g/ton of bacitracin (as BMD®). Feed this complete Type C medicated feed as the sole ration.

Oral

Coxidin® and BMD®

Broiler chickens

500 grams chlortetracycline and 90 to 110 grams monensin per ton of Type C medicated feed.

Oral

ChlorMax® and Coban™

Chickens (Broiler)

Feed 20 g virginiamycin and 90 to 110 g monensin per ton of feed continuously as the sole ration for broiler chickens.

Oral

Feed continuously as the sole ration for broiler chickens. Do not feed to laying chickens. Do not administer to chickens producing eggs for human consumption. The use of monensin with no withdrawal period may limit feed intake reducing weight gain. Do not allow horses or other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses and guinea fowl has been fatal. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Stafac® and Coban™

Chickens (broiler)

13.6 to 40.9 grams avilamycin per ton and 90 to 110 grams monensin activity per ton of Type C medicated feed.

Oral

Feed this complete Type C medicated feed as the sole ration for 21 consecutive days. Feed to chickens that are at risk of developing, but not yet showing clinical signs of necrotic enteritis associated with Clostridium perfringens in broiler chickens. To assure responsible antimicrobial drug use in broiler chickens, treatment administration must begin on or before 18 days of age. The safety of avilamycin has not been established in chickens intended for breeding purposes. Avilamycin has not been demonstrated to be effective in broiler chickens showing clinical signs of necrotic enteritis prior to the start of medication. In the absence of coccidiosis in broiler chickens the use of monensin with no withdrawal period may limit feed intake resulting in reduced weight gain. Not for broiler breeder replacement chickens. Do not feed to laying chickens. Do not feed to chickens over 16 weeks of age. Do not allow horses,equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses and guinea fowl has been fatal.

Inteprity™ and Coban™

Laying hen replacement chickens and layer breeder replacement chickens

50 g/ton of bacitracin (as feed grade bacitracin methylenedisalicylate provided by Pennitracin MD®) and 90 to 110 g/ton of monensin (as Coban™). Feed as the sole ration for 28 to 35 days, starting from the time chicks are placed for brooding.

Oral

Pennitracin MD® and Coban™

Laying hen replacement chickens and layer breeder replacement chickens

4 to 50 g/ton of bacitracin (as feed grade bacitracin methylenedisalicylate provided by Pennitracin MD®) and 90 to 110 g/ton of monensin (as Coban™). Feed as the sole ration throughout the feeding period.

Oral

Pennitracin MD® and Coban™

Broiler Chickens, Laying Hen Replacement Chickens, and Layer Breeder Replacement Chickens:

Feed complete feed (90 to 110 g/ton) continuously as the sole ration.

Oral, in feed

Coxidin® 90

Growing Turkeys

54 to 90 grams monensin, USP, per ton of Type C medicated feed. Feed as the sole ration. The optimum level depends upon the severity of coccidiosis exposure.

Oral

Do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses and guinea fowl has been fatal. Some strains of turkey coccidia may be monensin tolerant or resistant. Monensin may interfere with development of immunity to turkey coccidiosis. Not for broiler breeder replacement chickens.

Coban™ 90

Growing Turkeys

Feed complete feed (54 to 90 g/ton) continuously as the sole ration. The optimum level depends upon the severity of coccidiosis exposure.

Oral, in feed

Coxidin® 90

Growing Turkeys

Monensin, 54 to 90 grams per ton of feed, and bacitracin methylene disalicylate, 4 to 50 grams per ton of feed.

Oral

For growing turkeys only. As monensin sodium. Feed continuously as sole ration. Do not allow horses, other equines, mature turkeys or guinea fowl access to feed containing monensin. Ingestion of monensin by horses and guinea fowl has been fatal. Some strains of turkey coccidia may be monensin tolerant or resistant. Monensin may interfere with development of immunity to turkey coccidiosis.

BMD® / Coban®

Growing Turkeys

Monensin, 54 to 90 grams, plus bambermycins, 1 to 2 grams per ton

Oral

For growing turkeys only. Feed continuously as sole ration. Some strains of turkey coccidia may be monensin tolerant or resistant. Monensin may interfere with development of immunity to turkey coccidiosis. Do not allow horses or other equines access to formulations containing monensin. Ingestion of monensin by equines has been fatal. Must be thoroughly mixed in feeds before use. Do not feed undiluted.

Coban® / Flavomycin®

Growing Turkeys

Monensin, 54 to 90 grams, with virginiamycin, 10 to 20 grams.

Oral

For growing turkeys only. Feed continuously as sole ration. Do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses, mature turkeys, and guinea fowl has been fatal. Some strains of turkey coccidia may be monensin tolerant or resistant. Monensin may interfere with development of immunity to turkey coccidiosis. Do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses, mature turkeys, and guinea fowl has been fatal. Some strains of turkey coccidia may be monensin tolerant or resistant. Monensin may interfere with development of immunity to turkey coccidiosis.

Coban® / Stafac®

Ractopamine hydrochloride is added to feed at concentrations of 4.6 to 11.8 g/ton in finishing tom and hen turkeys fed for the last 7 to 14 days prior to slaughter. Monensin, USP is added to growing turkey feed at concentrations of 54 to 90 g/ton.

Oral

Not for animals intended for breeding.

Topmax™ plus Coban®

Growing turkeys

4 to 50 g/ton of bacitracin (as feed grade bacitracin methylenedisalicylate provided by Pennitracin MD®). Feed continuously as the sole ration. The optimum level depends upon the severity of coccidiosis exposure.

Oral

Pennitracin MD® and Coban™

Growing turkeys

4 to 50 g/ton of bacitracin (as Pennitracin MD®) and 54 to 90 g/ton of monensin (as Coxidin®). Feed continuously as the sole ration. The optimum level depends upon the severity of coccidiosis exposure.

Oral

Pennitracin MD® and Coxidin®

Growing turkeys

54 to 90 g/ton of monensin (as Coxidin®) and 1 to 2 g/ton of bambermycins (as Flavomycin®). Feed this complete Type C medicated feed as the sole ration.

Oral

Coxidin® and Flavomycin®

Growing turkeys

54 to 90 g/ton of monensin (as Coban™). Feed continuously as the sole ration. The optimum level depends upon the severity of coccidiosis exposure.

Oral

Pennitracin MD® and Coban™

Growing turkeys

54 to 90 g/ton of monensin (as Coxidin®) and 200 g/ton of bacitracin (as BMD®). Feed this complete Type C medicated feed as the sole ration.

Oral

Coxidin® and BMD®

Goats maintained in confinement except reproducing or lactating goats

Feed complete feed (20 g/ton) continuously to goats as the sole ration. Feed only to goats maintained in confinement.

Oral

Monovet® 90

Goats maintained in confinement except reproducing or lactating goats

20 grams per ton of complete feed continuously as the sole ration.

Oral

Feed only to goats maintained in confinement. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Rumensin™ 90

Growing Bobwhite Quail

73 grams monensin, USP, per ton of Type C medicated feed. Feed as the sole ration.

Oral

Do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses and guinea fowl has been fatal. Not for broiler breeder replacement chickens.

Coban™ 90

Growing Bobwhite Quail

Feed complete feed (73 g/ton) continuously as the sole ration.

Oral, in feed

Coxidin® 90

Please see NADA 125-476 for more information

Oral

Please see NADA 125-476 for more information

MGA® 100-200 / Rumensin®

Ractopamine is fed at a concentration of 9.8 to 24.6 g of ractopamine per ton of complete feed (based on 90% dry matter basis) to provide 90-430 mg ractopamine/head/day in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. Monensin is added to feedlot cattle diets at concentrations of 10 to 40 g monensin USP per ton of complete feed to provide 0.14 to 0.42 mg monensin/lb of body weight/day, depending on severity of coccidiosis challenge, up to a maximum of 480 mg monensin/head/day. Tylosin is added to the cattle diets at concentrations of 8 to 10 g tylosin phosphate per ton complete feed to provide 60 to 90 mg tylosin/head/day. Melengestrol acetate is added to the diet of heifers at 0.5 to 2.0 pounds per head per day of medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound to provide 0.25 to 0.5 mg melengestrol acetate per head per day in heifers fed in confinement for slaughter. Feed melengestrol acetate in this combination for the final 28 to 42 days.

Oral

Feed continuously as sole ration during the last 28 to 42 days on feed. Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at time of loading. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Ractopamine HCl is not for animals intended for breeding. Do not use in calves to be processed for veal. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian. Special considerations: Mixing directions for liquid melengestrol acetate Type C feeds stored in recirculation tank systems, labeling indicates: “Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents from the bottom of the tank to the top. Recirculate daily, as directed in this paragraph even when the Type C feed is not used.” For liquid melengestrol Type C feeds stored in mechanical, air or other agitation-type tank systems: “Agitate immediately prior to use for not less than 10 minutes, creating turbulence at the bottom of the tank that is visible at the top. Agitate daily, as directed in this paragraph, even when the Type C feed is not used.”

Actogain™ 45/Rumensin®/Tylovet® 100/MGA®

Zilpaterol hydrochloride is fed at a concentration of 6.8 g of zilpaterol hydrochloride per ton of complete feed to provide 60 to 90 mg zilpaterol/head/day in cattle fed in confinement for slaughter during the last 20 to 40 days on feed. Monensin USP is added to diets for cattle fed in confinement for slaughter at concentrations of 10 to 40 g of monensin USP per ton of complete feed at a rate of 0.14 to 0.42 mg monensin/lb of body weight, depending on severity of coccidiosis challenge, up to 480 mg/head/day. Tylosin phosphate is added to the cattle diets at concentrations of 8 to 10 g of tylosin phosphate per ton of complete feed to provide 60 to 90 mg tylosin/head/day.

Oral

Do not use in calves to be processed for veal. Feed continuously as the sole ration during the last 20 to 40 days on feed. Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90 percent dry matter basis), zilpaterol should not be fed in complete feed. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian. Special considerations: 1) Labeling of Type B and Type C cattle feeds shall bear the following: (i) Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. (ii) Zilpaterol hydrochloride is not for use in animals intended for breeding. (iii) Do not allow horses or other equines access to feed containing zilpaterol. (iv) Do not use in veal calves. 2) Type B Liquid Feeds can be manufactured containing 68 to 680 g zilpaterol hydrochloride/ton. The liquid Type B feeds must be maintained at a pH of 3.8 to 7.5. For liquid feeds stored in recirculating tank systems: Recirculate immediately prior to use for not less than 10 minutes, moving not less than 1 percent of the tank contents per minute from the bottom of the tank to the top. Recirculate daily as described even when not used. For liquid feeds stored in mechanical, air or other agitation-type tank systems: Agitate immediately prior to use for not less than 10 minutes, creating turbulence at the bottom of the tank that is visible at the top. Agitate daily as described even when not used.

Zilmax®/Rumensin®/Tylovet® 100

Mixing Directions (Broiler Chickens, Laying Hen Replacement Chickens, and Layer Breeder Replacement Chickens) – Thoroughly mix the following amounts of Coban 90 with a sufficient quantity of unmedicated feed to make one ton of complete chicken feed to provide 90 through 110 grams monensin per ton. Monensin (Grams Per Ton) Coban 90 (Lbs Per Ton of Type C Feed) 90 0.99 95 1.05 100 1.10 105 1.16 110 1.21

ORAL

FDA application 038-878

Mixing Directions (Turkeys) – Thoroughly mix the following amounts of Coban 90 with a sufficient quantity of unmedicated feed to make one ton of complete turkey feed to provide 54 through 90 grams monensin per ton. Monensin (Grams Per Ton) Coban 90 (Lbs Per Ton of Type C Feed) 54 0.60 66 0.73 78 0.86 90 0.99

ORAL

FDA application 038-878

Mixing Directions (Bobwhite Quail) – Thoroughly mix the following amounts of Coban 90 with a sufficient quantity of unmedicated feed to make one ton of complete quail feed to provide 73 grams monensin per ton. Monensin (Grams Per Ton) Coban 90 (Lbs Per Ton of Type C Feed) 73 0.80

ORAL

FDA application 038-878

Ractopamine hydrochloride (8.2 to 24.6 g/ton) in combination with monensin USP (10 to 40 g/ton).

Oral

Feed continuously as sole ration for the last 28 to 42 days on ration. Not for animals intended for breeding. Do not use in calves to be processed for veal. Ractopamine hydrochloride (9.8 to 24.6 g/ton) in combination with monensin USP (10 to 40 g/ton).

Actogain™ 45 plus Rumensin®